Drugs@FDA: FDA-Approved Drugs
Recent New and Generic Drug Approvals
This report displays final approvals and tentative approvals of original and supplemental applications for the two weeks beginning on the earliest date listed below. Some approvals may be added to the Drugs@FDA database after this timespan. For comprehensive approval reports, please use the monthly "All Approvals" report on Drugs@FDA.
May 2, 2024
Drug Name and Application Number |
Active Ingredient | Dosage Form/ Route | Submission | Company | Submission Classification | Submission Status |
---|---|---|---|---|---|---|
Esmolol Hydrochloride Double Strength In Plastic Container
NDA #205703 |
Esmolol Hydrochloride | Solution; Intravenous | SUPPL-3 | Hq Spclt Pharma | Labeling | Approved |
Esmolol Hydrochloride In Plastic Container
NDA #205703 |
Esmolol Hydrochloride | Solution; Intravenous | SUPPL-3 | Hq Spclt Pharma | Labeling | Approved |
May 1, 2024
Drug Name and Application Number |
Active Ingredient | Dosage Form/ Route | Submission | Company | Submission Classification | Submission Status |
---|---|---|---|---|---|---|
Amoxicillin
ANDA #061926 |
Amoxicillin | Capsule; Oral | SUPPL-136 | Teva | Labeling | Approved |
Amoxicillin
ANDA #061931 |
Amoxicillin | For Suspension; Oral | SUPPL-60 | Teva | Labeling | Approved |
Amoxicillin
ANDA #062058 |
Amoxicillin | Capsule; Oral | SUPPL-15 | Chartwell | Labeling | Approved |
Amoxicillin
ANDA #062059 |
Amoxicillin | For Suspension; Oral | SUPPL-6 | Chartwell Rx | Labeling | Approved |
Amoxicillin
ANDA #062881 |
Amoxicillin | Capsule; Oral | SUPPL-29 | Strides Pharma | Labeling | Approved |
Amoxicillin
ANDA #062884 |
Amoxicillin | Capsule; Oral | SUPPL-26 | Strides Pharma | Labeling | Approved |
Amoxicillin
ANDA #062927 |
Amoxicillin | For Suspension; Oral | SUPPL-29 | Dava Pharms Inc | Labeling | Approved |
Amoxicillin
ANDA #064013 |
Amoxicillin | Tablet, Chewable; Oral | SUPPL-64 | Teva | Labeling | Approved |
Amoxicillin
ANDA #064076 |
Amoxicillin | Capsule; Oral | SUPPL-38 | Sandoz | Labeling | Approved |
Amoxicillin
ANDA #064139 |
Amoxicillin | Tablet, Chewable; Oral | SUPPL-16 | Chartwell Rx | Labeling | Approved |
Amoxicillin
ANDA #065056 |
Amoxicillin | Tablet; Oral | SUPPL-26 | Teva | Labeling | Approved |
Amoxicillin
ANDA #065119 |
Amoxicillin | For Suspension; Oral | SUPPL-33 | Teva | Labeling | Approved |
Amoxicillin
ANDA #065228 |
Amoxicillin | Tablet; Oral | SUPPL-20 | Sandoz | Labeling | Approved |
Amoxicillin
ANDA #065255 |
Amoxicillin | Tablet; Oral | SUPPL-28 | Hikma | Labeling | Approved |
Amoxicillin
ANDA #065256 |
Amoxicillin | Tablet; Oral | SUPPL-25 | Aurobindo | Labeling | Approved |
Amoxicillin
ANDA #065271 |
Amoxicillin | Capsule; Oral | SUPPL-25 | Aurobindo | Labeling | Approved |
Amoxicillin
ANDA #065291 |
Amoxicillin | Capsule; Oral | SUPPL-33 | Hikma Pharms | Labeling | Approved |
Amoxicillin
ANDA #065322 |
Amoxicillin | For Suspension; Oral | SUPPL-39 | Hikma | Labeling | Approved |
Amoxicillin
ANDA #065325 |
Amoxicillin | For Suspension; Oral | SUPPL-35 | Hikma | Labeling | Approved |
Amoxicillin
ANDA #065334 |
Amoxicillin | For Suspension; Oral | SUPPL-25 | Aurobindo | Labeling | Approved |
Amoxicillin
ANDA #065344 |
Amoxicillin | Tablet; Oral | SUPPL-8 | Chartwell Rx | Labeling | Approved |
Amoxicillin
ANDA #065378 |
Amoxicillin | For Suspension; Oral | SUPPL-19 | Sandoz | Labeling | Approved |
Amoxicillin
ANDA #065387 |
Amoxicillin | For Suspension; Oral | SUPPL-19 | Sandoz | Labeling | Approved |
Amoxicillin
ANDA #204030 |
Amoxicillin | For Suspension; Oral | SUPPL-13 | Aurobindo Pharma Ltd | Labeling | Approved |
Amoxicillin
ANDA #207471 |
Amoxicillin | Capsule; Oral | SUPPL-2 | Micro Labs | Labeling | Approved |
Amoxicillin and Clavulanate Potassium
ANDA #065063 |
Amoxicillin; Clavulanate Potassium | Tablet; Oral | SUPPL-51 | Sandoz | Labeling | Approved |
Amoxicillin and Clavulanate Potassium
ANDA #065064 |
Amoxicillin; Clavulanate Potassium | Tablet; Oral | SUPPL-50 | Sandoz | Labeling | Approved |
Amoxicillin and Clavulanate Potassium
ANDA #065065 |
Amoxicillin; Clavulanate Potassium | Tablet, Chewable; Oral | SUPPL-35 | Sandoz | Labeling | Approved |
Amoxicillin and Clavulanate Potassium
ANDA #065066 |
Amoxicillin; Clavulanate Potassium | For Suspension; Oral | SUPPL-50 | Sandoz | Labeling | Approved |
Amoxicillin and Clavulanate Potassium
ANDA #065089 |
Amoxicillin; Clavulanate Potassium | For Suspension; Oral | SUPPL-30 | Teva | Labeling | Approved |
Amoxicillin and Clavulanate Potassium
ANDA #065093 |
Amoxicillin; Clavulanate Potassium | Tablet; Oral | SUPPL-33 | Sandoz Inc | Labeling | Approved |
Amoxicillin and Clavulanate Potassium
ANDA #065096 |
Amoxicillin; Clavulanate Potassium | Tablet; Oral | SUPPL-39 | Teva Pharms Usa | Labeling | Approved |
Amoxicillin and Clavulanate Potassium
ANDA #065096 |
Amoxicillin; Clavulanate Potassium | Tablet; Oral | SUPPL-39 | Teva Pharms Usa | Labeling | Approved |
Amoxicillin and Clavulanate Potassium
ANDA #065098 |
Amoxicillin; Clavulanate Potassium | For Suspension; Oral | SUPPL-25 | Sandoz Inc | Labeling | Approved |
Amoxicillin and Clavulanate Potassium
ANDA #065101 |
Amoxicillin; Clavulanate Potassium | Tablet; Oral | SUPPL-38 | Teva | Labeling | Approved |
Amoxicillin and Clavulanate Potassium
ANDA #065117 |
Amoxicillin; Clavulanate Potassium | Tablet; Oral | SUPPL-34 | Sandoz Inc | Labeling | Approved |
Amoxicillin and Clavulanate Potassium
ANDA #065162 |
Amoxicillin; Clavulanate Potassium | For Suspension; Oral | SUPPL-40 | Teva | Labeling | Approved |
Amoxicillin and Clavulanate Potassium
ANDA #065162 |
Amoxicillin; Clavulanate Potassium | For Suspension; Oral | SUPPL-40 | Teva | Labeling | Approved |
Amoxicillin and Clavulanate Potassium
ANDA #065189 |
Amoxicillin; Clavulanate Potassium | Tablet; Oral | SUPPL-30 | Sandoz | Labeling | Approved |
Amoxicillin and Clavulanate Potassium
ANDA #065191 |
Amoxicillin; Clavulanate Potassium | For Suspension; Oral | SUPPL-35 | Hikma Pharms | Labeling | Approved |
Amoxicillin and Clavulanate Potassium
ANDA #065205 |
Amoxicillin; Clavulanate Potassium | Tablet, Chewable; Oral | SUPPL-30 | Teva | Labeling | Approved |
Amoxicillin and Clavulanate Potassium
ANDA #065317 |
Amoxicillin; Clavulanate Potassium | Tablet; Oral | SUPPL-4 | Apotex Inc | Labeling | Approved |
Amoxicillin and Clavulanate Potassium
ANDA #065317 |
Amoxicillin; Clavulanate Potassium | Tablet; Oral | SUPPL-4 | Apotex Inc | Labeling | Approved |
Amoxicillin and Clavulanate Potassium
ANDA #065333 |
Amoxicillin; Clavulanate Potassium | Tablet; Oral | SUPPL-4 | Apotex Inc | Labeling | Approved |
Amoxicillin and Clavulanate Potassium
ANDA #065333 |
Amoxicillin; Clavulanate Potassium | Tablet; Oral | SUPPL-4 | Apotex Inc | Labeling | Approved |
Amoxicillin and Clavulanate Potassium
ANDA #065373 |
Amoxicillin; Clavulanate Potassium | For Suspension; Oral | SUPPL-27 | Hikma Pharms | Labeling | Approved |
Amoxicillin and Clavulanate Potassium
ANDA #065373 |
Amoxicillin; Clavulanate Potassium | For Suspension; Oral | SUPPL-23 | Hikma Pharms | Labeling | Approved |
Amoxicillin and Clavulanate Potassium
ANDA #065373 |
Amoxicillin; Clavulanate Potassium | For Suspension; Oral | SUPPL-27 | Hikma Pharms | Labeling | Approved |
Amoxicillin and Clavulanate Potassium
ANDA #065373 |
Amoxicillin; Clavulanate Potassium | For Suspension; Oral | SUPPL-30 | Hikma Pharms | Labeling | Approved |
Amoxicillin and Clavulanate Potassium
ANDA #090227 |
Amoxicillin; Clavulanate Potassium | Tablet, Extended Release; Oral | SUPPL-19 | Sandoz | Labeling | Approved |
Amoxicillin and Clavulanate Potassium
ANDA #201090 |
Amoxicillin; Clavulanate Potassium | For Suspension; Oral | SUPPL-14 | Aurobindo Pharma Ltd | Labeling | Approved |
Amoxicillin and Clavulanate Potassium
ANDA #201091 |
Amoxicillin; Clavulanate Potassium | For Suspension; Oral | SUPPL-13 | Aurobindo Pharma Ltd | Labeling | Approved |
Amoxicillin and Clavulanate Potassium
ANDA #204755 |
Amoxicillin; Clavulanate Potassium | Tablet; Oral | SUPPL-12 | Micro Labs Ltd India | Labeling | Approved |
Amoxicillin and Clavulanate Potassium
ANDA #205187 |
Amoxicillin; Clavulanate Potassium | For Suspension; Oral | SUPPL-4 | Micro Labs Ltd India | Labeling | Approved |
Amoxicillin and Clavulanate Potassium
ANDA #205707 |
Amoxicillin; Clavulanate Potassium | Tablet; Oral | SUPPL-12 | Micro Labs Ltd India | Labeling | Approved |
Amoxicillin Pediatric
ANDA #061931 |
Amoxicillin | For Suspension; Oral | SUPPL-60 | Teva | Labeling | Approved |
Amoxil
NDA #050542 |
Amoxicillin | Tablet, Chewable; Oral | SUPPL-32 | Us Antibiotics | Labeling | Approved |
Amoxil
NDA #050754 |
Amoxicillin | Tablet; Oral | SUPPL-22 | Us Antibiotics | Labeling | Approved |
Amoxil
NDA #050760 |
Amoxicillin | For Suspension; Oral | SUPPL-23 | Us Antibiotics | Labeling | Approved |
Amoxil
NDA #050761 |
Amoxicillin | Tablet, Chewable; Oral | SUPPL-19 | Us Antibiotics | Labeling | Approved |
Amoxil
ANDA #062216 |
Amoxicillin | Capsule; Oral | SUPPL-44 | Us Antibiotics | Labeling | Approved |
Amoxil
ANDA #062216 |
Amoxicillin | Capsule; Oral | SUPPL-44 | Us Antibiotics | Labeling | Approved |
Amoxil
ANDA #062226 |
Amoxicillin | For Suspension; Oral | SUPPL-40 | Us Antibiotics | Labeling | Approved |
Ampicillin Sodium
ANDA #061395 |
Ampicillin Sodium | Injectable; Injection | SUPPL-52 | Sandoz | Labeling | Approved |
Ampicillin Sodium
ANDA #062692 |
Ampicillin Sodium | Injectable; Injection | SUPPL-2 | Hikma | Labeling | Approved |
Ampicillin Sodium
ANDA #062719 |
Ampicillin Sodium | Injectable; Injection | SUPPL-16 | Istituto Bio Ita Spa | Labeling | Approved |
Ampicillin Sodium
ANDA #062738 |
Ampicillin Sodium | Powder; Intravenous | SUPPL-33 | Sandoz | Labeling | Approved |
Ampicillin Sodium
ANDA #062772 |
Ampicillin Sodium | Injectable; Injection | SUPPL-17 | Hq Speclt Pharma | Labeling | Approved |
Ampicillin Sodium
ANDA #062797 |
Ampicillin Sodium | Injectable; Injection | SUPPL-13 | Istituto Bio Ita Spa | Labeling | Approved |
Ampicillin Sodium
ANDA #063142 |
Ampicillin Sodium | Injectable; Injection | SUPPL-18 | Hq Speclt Pharma | Labeling | Approved |
Ampicillin Sodium
ANDA #065493 |
Ampicillin Sodium | Injectable; Injection | SUPPL-11 | Eugia Pharma Speclts | Labeling | Approved |
Ampicillin Sodium
ANDA #065499 |
Ampicillin Sodium | Injectable; Injection | SUPPL-13 | Eugia Pharma Speclts | Labeling | Approved |
Ampicillin Sodium
ANDA #090354 |
Ampicillin Sodium | Injectable; Injection | SUPPL-7 | Antibiotice | Labeling | Approved |
Ampicillin Sodium
ANDA #090581 |
Ampicillin Sodium | Injectable; Injection | SUPPL-5 | Sagent Pharms Inc | Labeling | Approved |
Ampicillin Sodium
ANDA #090583 |
Ampicillin Sodium | Injectable; Injection | SUPPL-5 | Sagent Pharms Inc | Labeling | Approved |
Ampicillin Sodium
ANDA #090884 |
Ampicillin Sodium | Injectable; Injection | SUPPL-3 | Acs Dobfar Spa | Labeling | Approved |
Ampicillin Sodium
ANDA #090889 |
Ampicillin Sodium | Injectable; Injection | SUPPL-3 | Acs Dobfar Spa | Labeling | Approved |
Ampicillin Sodium
ANDA #201025 |
Ampicillin Sodium | Injectable; Injection | SUPPL-10 | Steriscience | Labeling | Approved |
Ampicillin Sodium
ANDA #201404 |
Ampicillin Sodium | Injectable; Injection | SUPPL-8 | Istituto Bio Ita Spa | Labeling | Approved |
Ampicillin Sodium
ANDA #202198 |
Ampicillin Sodium | Injectable; Injection | SUPPL-7 | Steriscience | Labeling | Approved |
Ampicillin Trihydrate
ANDA #061502 |
Ampicillin/Ampicillin Trihydrate | Capsule; Oral | SUPPL-140 | Chartwell Rx | Labeling | Approved |
Ampicillin Trihydrate
ANDA #062882 |
Ampicillin/Ampicillin Trihydrate | Capsule; Oral | SUPPL-17 | Strides Pharma | Labeling | Approved |
Ampicillin Trihydrate
ANDA #062883 |
Ampicillin/Ampicillin Trihydrate | Capsule; Oral | SUPPL-15 | Strides Pharma | Labeling | Approved |
Ampicillin Trihydrate
ANDA #062982 |
Ampicillin/Ampicillin Trihydrate | For Suspension; Oral | SUPPL-16 | Dava Pharms Inc | Labeling | Approved |
Ampicillin Trihydrate
ANDA #064082 |
Ampicillin/Ampicillin Trihydrate | Capsule; Oral | SUPPL-22 | Sandoz | Labeling | Approved |
Ampicillin Trihydrate
ANDA #216554 |
Ampicillin/Ampicillin Trihydrate | Capsule; Oral | SUPPL-1 | Aurobindo Pharma | Labeling | Approved |
Augmentin '125'
NDA #050575 |
Amoxicillin; Clavulanate Potassium | For Suspension; Oral | SUPPL-51 | Us Antibiotics | Labeling | Approved |
Augmentin '125'
NDA #050597 |
Amoxicillin; Clavulanate Potassium | Tablet, Chewable; Oral | SUPPL-52 | Us Antibiotics | Labeling | Approved |
Augmentin '200'
NDA #050725 |
Amoxicillin; Clavulanate Potassium | For Suspension; Oral | SUPPL-36 | Us Antibiotics | Labeling | Approved |
Augmentin '200'
NDA #050726 |
Amoxicillin; Clavulanate Potassium | Tablet, Chewable; Oral | SUPPL-27 | Us Antibiotics | Labeling | Approved |
Augmentin '250'
NDA #050564 |
Amoxicillin; Clavulanate Potassium | Tablet; Oral | SUPPL-60 | Us Antibiotics | Labeling | Approved |
Augmentin '250'
NDA #050575 |
Amoxicillin; Clavulanate Potassium | For Suspension; Oral | SUPPL-51 | Us Antibiotics | Labeling | Approved |
Augmentin '250'
NDA #050597 |
Amoxicillin; Clavulanate Potassium | Tablet, Chewable; Oral | SUPPL-52 | Us Antibiotics | Labeling | Approved |
Augmentin '400'
NDA #050725 |
Amoxicillin; Clavulanate Potassium | For Suspension; Oral | SUPPL-36 | Us Antibiotics | Labeling | Approved |
Augmentin '400'
NDA #050726 |
Amoxicillin; Clavulanate Potassium | Tablet, Chewable; Oral | SUPPL-27 | Us Antibiotics | Labeling | Approved |
Augmentin '500'
NDA #050564 |
Amoxicillin; Clavulanate Potassium | Tablet; Oral | SUPPL-60 | Us Antibiotics | Labeling | Approved |
Augmentin '875'
NDA #050720 |
Amoxicillin; Clavulanate Potassium | Tablet; Oral | SUPPL-37 | Us Antibiotics | Labeling | Approved |
Augmentin Es-600
NDA #050755 |
Amoxicillin; Clavulanate Potassium | For Suspension; Oral | SUPPL-29 | Us Antibiotics | Labeling | Approved |
Augmentin Xr
NDA #050785 |
Amoxicillin; Clavulanate Potassium | Tablet, Extended Release; Oral | SUPPL-18 | Us Antibiotics | Labeling | Approved |
Dexmedetomidine Hydrochloride
ANDA #203972 |
Dexmedetomidine Hydrochloride | Injectable; Injection | SUPPL-14 | Par Sterile Products | Labeling | Approved |
Dexmedetomidine Hydrochloride
ANDA #203972 |
Dexmedetomidine Hydrochloride | Injectable; Injection | SUPPL-15 | Par Sterile Products | Labeling | Approved |
Dexmedetomidine Hydrochloride
ANDA #208266 |
Dexmedetomidine Hydrochloride | Injectable; Injection | SUPPL-9 | Par Sterile Products | Labeling | Approved |
Etodolac
ANDA #204729 |
Etodolac | Tablet; Oral | ORIG-1 | Ipca Labs Ltd | Approved | |
Lansoprazole, Amoxicillin and Clarithromycin (Copackaged)
ANDA #200218 |
Amoxicillin; Clarithromycin; Lansoprazole | Capsule, Tablet, Capsule, Delayed Rel Pellets; Oral | SUPPL-12 | Ani Pharms | Labeling | Approved |
Larotid
ANDA #062226 |
Amoxicillin | For Suspension; Oral | SUPPL-40 | Us Antibiotics | Labeling | Approved |
Memantine;Donepezil Hydrochlorides
ANDA #216901 |
Memantine;Donepezil Hydrochlorides | Capsule, Extended Release; Oral | ORIG-1 | Xiamen Lp Pharm Co | Tentative Approval | |
Moxatag
NDA #050813 |
Amoxicillin | Tablet, Extended Release; Oral | SUPPL-10 | Pragma | Labeling | Approved |
Mycophenolate Mofetil
ANDA #212634 |
Mycophenolate Mofetil | For Suspension; Oral | SUPPL-1 | Strides Pharma | Labeling | Approved |
Mycophenolate Mofetil
ANDA #212634 |
Mycophenolate Mofetil | For Suspension; Oral | SUPPL-1 | Strides Pharma | Labeling | Approved |
Myhibbin
NDA #216482 |
Mycophenolate Mofetil | Suspension; Oral | ORIG-1 | Azurity Pharmaceuticals Inc | Type 5 - New Formulation or New Manufacturer | Approved |
Omeprazole and Clarithromycin and Amoxicillin
NDA #050824 |
Amoxicillin; Clarithromycin; Omeprazole | Capsule, Tablet, Capsule, Delayed Release; Oral | SUPPL-13 | Cumberland | Labeling | Approved |
Oseltamivir Phosphate
ANDA #218565 |
Oseltamivir Phosphate | Capsule; Oral | ORIG-1 | Laurus | Approved | |
Oxymorphone Hydrochloride
ANDA #204459 |
Oxymorphone Hydrochloride | Tablet; Oral | SUPPL-7 | Aurolife Pharma Llc | Labeling | Approved |
Oxymorphone Hydrochloride
ANDA #204459 |
Oxymorphone Hydrochloride | Tablet; Oral | SUPPL-8 | Aurolife Pharma Llc | Labeling | Approved |
Oxymorphone Hydrochloride
ANDA #204459 |
Oxymorphone Hydrochloride | Tablet; Oral | SUPPL-9 | Aurolife Pharma Llc | Labeling | Approved |
Oxymorphone Hydrochloride
ANDA #204459 |
Oxymorphone Hydrochloride | Tablet; Oral | SUPPL-10 | Aurolife Pharma Llc | Labeling | Approved |
Oxymorphone Hydrochloride
ANDA #204459 |
Oxymorphone Hydrochloride | Tablet; Oral | SUPPL-7 | Aurolife Pharma Llc | Labeling | Approved |
Oxymorphone Hydrochloride
ANDA #204459 |
Oxymorphone Hydrochloride | Tablet; Oral | SUPPL-8 | Aurolife Pharma Llc | Labeling | Approved |
Oxymorphone Hydrochloride
ANDA #204459 |
Oxymorphone Hydrochloride | Tablet; Oral | SUPPL-9 | Aurolife Pharma Llc | Labeling | Approved |
Oxymorphone Hydrochloride
ANDA #204459 |
Oxymorphone Hydrochloride | Tablet; Oral | SUPPL-10 | Aurolife Pharma Llc | Labeling | Approved |
Piperacillin
ANDA #065114 |
Piperacillin Sodium | Injectable; Injection | SUPPL-18 | Istituto Bio Ita Spa | Labeling | Approved |
Piperacillin
ANDA #065157 |
Piperacillin Sodium | Injectable; Injection | SUPPL-15 | Istituto Bio Ita Spa | Labeling | Approved |
Piperacillin and Tazobactam
ANDA #065362 |
Piperacillin Sodium; Tazobactam Sodium | Injectable; Injection | SUPPL-44 | Sandoz | Labeling | Approved |
Piperacillin and Tazobactam
ANDA #065363 |
Piperacillin Sodium; Tazobactam Sodium | Injectable; Injection | SUPPL-47 | Sandoz | Labeling | Approved |
Piperacillin and Tazobactam
ANDA #065458 |
Piperacillin Sodium; Tazobactam Sodium | Injectable; Injection | SUPPL-16 | Steriscience | Labeling | Approved |
Piperacillin and Tazobactam
ANDA #065498 |
Piperacillin Sodium; Tazobactam Sodium | Injectable; Injection | SUPPL-26 | Eugia Pharma Speclts | Labeling | Approved |
Piperacillin and Tazobactam
ANDA #065523 |
Piperacillin Sodium; Tazobactam Sodium | Injectable; Injection | SUPPL-30 | Istituto Bio Ita Spa | Labeling | Approved |
Piperacillin and Tazobactam
ANDA #090498 |
Piperacillin Sodium; Tazobactam Sodium | Injectable; Injection | SUPPL-24 | Istituto Bio Ita Spa | Labeling | Approved |
Piperacillin and Tazobactam
ANDA #203557 |
Piperacillin Sodium; Tazobactam Sodium | Injectable; Injection | SUPPL-35 | Sandoz | Labeling | Approved |
Piperacillin and Tazobactam
ANDA #203719 |
Piperacillin Sodium; Tazobactam Sodium | Injectable; Injection | SUPPL-12 | Fresenius Kabi | Labeling | Approved |
Piperacillin and Tazobactam
ANDA #203720 |
Piperacillin Sodium; Tazobactam Sodium | Injectable; Injection | SUPPL-11 | Fresenius Kabi | Labeling | Approved |
Piperacillin and Tazobactam
ANDA #204959 |
Piperacillin Sodium; Tazobactam Sodium | Injectable; Injection | SUPPL-13 | Shandong | Labeling | Approved |
Piperacillin and Tazobactam
ANDA #206996 |
Piperacillin Sodium; Tazobactam Sodium | Injectable; Injection | SUPPL-9 | Wockhardt Bio Ag | Labeling | Approved |
Piperacillin and Tazobactam
ANDA #207146 |
Piperacillin Sodium; Tazobactam Sodium | Injectable; Injection | SUPPL-9 | Wockhardt Bio Ag | Labeling | Approved |
Piperacillin and Tazobactam
ANDA #207847 |
Piperacillin Sodium; Tazobactam Sodium | Injectable; Injection | SUPPL-15 | Provepharm Sas | Labeling | Approved |
Piperacillin and Tazobactam
ANDA #207848 |
Piperacillin Sodium; Tazobactam Sodium | Injectable; Injection | SUPPL-15 | Provepharm Sas | Labeling | Approved |
Piperacillin and Tazobactam
ANDA #208674 |
Piperacillin Sodium; Tazobactam Sodium | Injectable; Injection | SUPPL-5 | Sagent Pharms Inc | Labeling | Approved |
Piperacillin and Tazobactam
ANDA #208675 |
Piperacillin Sodium; Tazobactam Sodium | Injectable; Injection | SUPPL-5 | Sagent Pharms Inc | Labeling | Approved |
Piperacillin and Tazobactam
ANDA #217243 |
Piperacillin Sodium; Tazobactam Sodium | Injectable; Injection | SUPPL-4 | Shandong | Labeling | Approved |
Piperacillin and Tazobactam
ANDA #217409 |
Piperacillin Sodium; Tazobactam Sodium | Injectable; Injection | SUPPL-1 | Eugia Pharma | Labeling | Approved |
Piperacillin and Tazobactam
ANDA #217409 |
Piperacillin,Tazobactam | Injection; Powder,For Solution | SUPPL-1 | Eugia Pharma | Labeling | Approved |
Probampacin
ANDA #061741 |
Ampicillin/Ampicillin Trihydrate; Probenecid | For Suspension; Oral | SUPPL-1 | Cosette | Labeling | Approved |
Sugammadex
ANDA #214230 |
Sugammadex | Injectable; Injection | ORIG-1 | Mankind Pharma | Tentative Approval | |
Talicia
NDA #213004 |
Amoxicillin; Omeprazole Magnesium; Rifabutin | Capsule, Delayed Release; Oral | SUPPL-14 | Redhill | Labeling | Approved |
Unasyn
NDA #050608 |
Ampicillin Sodium; Sulbactam Sodium | Injectable; Injection | SUPPL-53 | Pfizer | Labeling | Approved |
Voquezna Dual Pak
NDA #215153 |
Amoxicillin; Vonoprazan Fumarate | Capsule, Tablet; Oral | SUPPL-7 | Phathom | Labeling | Approved |
Voquezna Triple Pak
NDA #215152 |
Amoxicillin; Clarithromycin; Vonoprazan Fumarate | Capsule, Tablet, Tablet; Oral | SUPPL-7 | Phathom | Labeling | Approved |
Zosyn
NDA #050684 |
Piperacillin Sodium; Tazobactam Sodium | Injectable; Injection | SUPPL-104 | Wyeth Pharms | Labeling | Approved |
Zosyn In Plastic Container
NDA #050750 |
Piperacillin Sodium; Tazobactam Sodium | Injectable; Injection | SUPPL-51 | Baxter Hlthcare Corp | Labeling | Approved |
April 30, 2024
Drug Name and Application Number |
Active Ingredient | Dosage Form/ Route | Submission | Company | Submission Classification | Submission Status |
---|---|---|---|---|---|---|
Abrilada
BLA #761118 |
Adalimumab-Afzb | Injectable; Injection | SUPPL-12 | Pfizer Inc | Labeling | Approved |
Abrilada
BLA #761118 |
Adalimumab-Afzb | Injectable; Injection | SUPPL-12 | Pfizer Inc | Labeling | Approved |
Amoxicillin and Clavulanate Potassium
ANDA #090227 |
Amoxicillin; Clavulanate Potassium | Tablet, Extended Release; Oral | SUPPL-18 | Sandoz | Labeling | Approved |
Amoxicillin and Clavulanate Potassium
ANDA #090227 |
Amoxicillin; Clavulanate Potassium | Tablet, Extended Release; Oral | SUPPL-18 | Sandoz | Labeling | Approved |
Aranesp
BLA #103951 |
Darbepoetin Alfa | Vial; Intravenous | SUPPL-5383 | Amgen | Labeling | Approved |
Aranesp
BLA #103951 |
Darbepoetin Alfa | Vial; Intravenous | SUPPL-5383 | Amgen | Labeling | Approved |
Aranesp
BLA #103951 |
Darbepoetin Alfa | Vial; Subcutaneous | SUPPL-5383 | Amgen | Labeling | Approved |
Aranesp
BLA #103951 |
Darbepoetin Alfa | Vial; Subcutaneous | SUPPL-5383 | Amgen | Labeling | Approved |
Bromfenac Sodium
ANDA #210962 |
Bromfenac Sodium | Unknown | ORIG-1 | Amneal Pharms Co | Tentative Approval | |
Camzyos
NDA #214998 |
Mavacamten | Capsule; Oral | SUPPL-9 | Bristol | Labeling | Approved |
Cupric Chloride
ANDA #216113 |
Cupric Chloride | Injectable; Injection | ORIG-1 | Somerset | Approved | |
Cupric Chloride
ANDA #217626 |
Cupric Chloride | Injectable; Injection | ORIG-1 | Stira | Approved | |
Cyltezo
BLA #761058 |
Adalimumab-Adbm | Injectable; Injection | SUPPL-26 | Boehringer Ingelheim | Efficacy | Approved |
Dimethyl Fumarate
ANDA #210531 |
Dimethyl Fumarate | Capsule, Delayed Release; Oral | SUPPL-3 | Mylan | Labeling | Approved |
Dimethyl Fumarate
ANDA #210531 |
Dimethyl Fumarate | Capsule, Delayed Release; Oral | SUPPL-6 | Mylan | Labeling | Approved |
Dimethyl Fumarate
ANDA #210531 |
Dimethyl Fumarate | Capsule, Delayed Release; Oral | SUPPL-10 | Mylan | Labeling | Approved |
Dimethyl Fumarate
ANDA #210531 |
Dimethyl Fumarate | Capsule, Delayed Release; Oral | SUPPL-12 | Mylan | Labeling | Approved |
Dimethyl Fumarate
ANDA #210531 |
Dimethyl Fumarate | Capsule, Delayed Release; Oral | SUPPL-3 | Mylan | Labeling | Approved |
Dimethyl Fumarate
ANDA #210531 |
Dimethyl Fumarate | Capsule, Delayed Release; Oral | SUPPL-6 | Mylan | Labeling | Approved |
Dimethyl Fumarate
ANDA #210531 |
Dimethyl Fumarate | Capsule, Delayed Release; Oral | SUPPL-10 | Mylan | Labeling | Approved |
Dimethyl Fumarate
ANDA #210531 |
Dimethyl Fumarate | Capsule, Delayed Release; Oral | SUPPL-12 | Mylan | Labeling | Approved |
Dimethyl Fumarate
ANDA #210531 |
Dimethyl Fumarate | Capsule, Delayed Release; Oral | SUPPL-13 | Mylan | Labeling | Approved |
Dofetilide
ANDA #212750 |
Dofetilide | Capsule; Oral | SUPPL-2 | Granules | Labeling | Approved |
Dofetilide
ANDA #212750 |
Dofetilide | Capsule; Oral | SUPPL-2 | Granules | Labeling | Approved |
Dofetilide
ANDA #212750 |
Dofetilide | Capsule; Oral | SUPPL-2 | Granules | Labeling | Approved |
Epogen/Procrit
BLA #103234 |
Epoetin Alfa | Vial; Multidose | SUPPL-5378 | Amgen | Labeling | Approved |
Epogen/Procrit
BLA #103234 |
Epoetin Alfa | Vial; Multidose | SUPPL-5378 | Amgen | Labeling | Approved |
Epogen/Procrit
BLA #103234 |
Epoetin Alfa | Vial; Single-Use | SUPPL-5378 | Amgen | Labeling | Approved |
Epogen/Procrit
BLA #103234 |
Epoetin Alfa | Vial; Single-Use | SUPPL-5378 | Amgen | Labeling | Approved |
Esomeprazole Magnesium
ANDA #207198 |
Esomeprazole Magnesium | Capsule, Delayed Release; Oral | ORIG-1 | Dr Reddys | Approved | |
Everolimus
ANDA #206133 |
Everolimus | Tablet; Oral | SUPPL-6 | Hikma | Labeling | Approved |
Ezetimibe
ANDA #207311 |
Ezetimibe | Tablet; Oral | SUPPL-12 | Ohm Labs Inc | Labeling | Approved |
Hydrochlorothiazide
ANDA #202556 |
Hydrochlorothiazide | Tablet; Oral | SUPPL-8 | Accord Hlthcare | Labeling | Approved |
Hydrochlorothiazide
ANDA #203561 |
Hydrochlorothiazide | Capsule; Oral | SUPPL-3 | Sciegen Pharms Inc | Labeling | Approved |
Hydrochlorothiazide
ANDA #203561 |
Hydrochlorothiazide | Capsule; Oral | SUPPL-5 | Sciegen Pharms Inc | Labeling | Approved |
Hydrocortisone Butyrate
ANDA #209556 |
Hydrocortisone Butyrate | Lotion; Topical | SUPPL-4 | The J Molner | Labeling | Approved |
Hydrocortisone Butyrate
ANDA #209556 |
Hydrocortisone Butyrate | Lotion; Topical | SUPPL-4 | The J Molner | Labeling | Approved |
Ingrezza Sprinkle
NDA #218390 |
Valbenazine | Capsule; Oral | ORIG-1 | Neurocrine | Approved | |
Linezolid
ANDA #204536 |
Linezolid | Tablet; Oral | SUPPL-7 | Amneal Pharms | Labeling | Approved |
Linezolid
ANDA #204536 |
Linezolid | Tablet; Oral | SUPPL-8 | Amneal Pharms | Labeling | Approved |
Linezolid
ANDA #204536 |
Linezolid | Tablet; Oral | SUPPL-9 | Amneal Pharms | Labeling | Approved |
Losartan Potassium and Hydrochlorothiazide
ANDA #201845 |
Hydrochlorothiazide; Losartan Potassium | Tablet; Oral | SUPPL-20 | Jubilant Cadista | Labeling | Approved |
Losartan Potassium and Hydrochlorothiazide
ANDA #201845 |
Hydrochlorothiazide; Losartan Potassium | Tablet; Oral | SUPPL-20 | Jubilant Cadista | Labeling | Approved |
Meperidine Hydrochloride
ANDA #040186 |
Meperidine Hydrochloride | Tablet; Oral | SUPPL-13 | Watson Labs | Labeling | Approved |
Meperidine Hydrochloride
ANDA #040186 |
Meperidine Hydrochloride | Tablet; Oral | SUPPL-13 | Watson Labs | Labeling | Approved |
Meperidine Hydrochloride
ANDA #080448 |
Meperidine Hydrochloride | Tablet; Oral | SUPPL-23 | Sun Pharm Industries | Labeling | Approved |
Meperidine Hydrochloride
ANDA #080448 |
Meperidine Hydrochloride | Tablet; Oral | SUPPL-23 | Sun Pharm Industries | Labeling | Approved |
Mircera
BLA #125164 |
Methoxy Polyethylene Glycol-Epoetin Beta | Solution; Injection | SUPPL-89 | Hoffman-La Roche | Efficacy | Approved |
Myfembree
NDA #214846 |
Estradiol; Norethindrone Acetate; Relugolix | Tablet; Oral | SUPPL-7 | Myovant Sciences | Efficacy | Approved |
Nicorette
NDA #022360 |
Nicotine Polacrilex | Troche/Lozenge; Oral | SUPPL-17 | Haleon Us Holdings | Labeling | Approved |
Nicotine Polacrilex
ANDA #076778 |
Nicotine Polacrilex | Gum, Chewing; Buccal | SUPPL-19 | L Perrigo Co | Labeling | Approved |
Nicotine Polacrilex
ANDA #076778 |
Nicotine Polacrilex | Gum, Chewing; Buccal | SUPPL-19 | L Perrigo Co | Labeling | Approved |
Norethindrone Acetate and Ethinyl Estradiol and Ferrous Fumarate
ANDA #202742 |
Ethinyl Estradiol; Norethindrone Acetate | Tablet; Oral | SUPPL-10 | Mylan Labs Ltd | Labeling | Approved |
Norethindrone Acetate and Ethinyl Estradiol and Ferrous Fumarate
ANDA #202742 |
Ethinyl Estradiol; Norethindrone Acetate | Tablet; Oral | SUPPL-12 | Mylan Labs Ltd | Labeling | Approved |
Pitavastatin Calcium
ANDA #205977 |
Pitavastatin Calcium | Tablet; Oral | ORIG-1 | Hetero Labs Ltd V | Approved | |
Sevelamer Carbonate
ANDA #207179 |
Sevelamer Carbonate | Tablet; Oral | SUPPL-11 | Aurobindo Pharma | Labeling | Approved |
Sotalol Hydrochloride
ANDA #077616 |
Sotalol Hydrochloride | Tablet; Oral | SUPPL-8 | Aurobindo Pharma Usa | Labeling | Approved |
Sotalol Hydrochloride
ANDA #077616 |
Sotalol Hydrochloride | Tablet; Oral | SUPPL-5 | Aurobindo Pharma Usa | Labeling | Approved |
Sotalol Hydrochloride
ANDA #077616 |
Sotalol Hydrochloride | Tablet; Oral | SUPPL-8 | Aurobindo Pharma Usa | Labeling | Approved |
Ursodiol
ANDA #075517 |
Ursodiol | Capsule; Oral | SUPPL-18 | Epic Pharma | Labeling | Approved |
Valsartan and Hydrochlorothiazide
ANDA #201662 |
Hydrochlorothiazide; Valsartan | Tablet; Oral | SUPPL-26 | Alembic | Labeling | Approved |
Valsartan and Hydrochlorothiazide
ANDA #201662 |
Hydrochlorothiazide; Valsartan | Tablet; Oral | SUPPL-26 | Alembic | Labeling | Approved |
Valsartan and Hydrochlorothiazide
ANDA #203000 |
Hydrochlorothiazide; Valsartan | Tablet; Oral | SUPPL-1 | Zydus Lifesciences | Labeling | Approved |
Valsartan and Hydrochlorothiazide
ANDA #203000 |
Hydrochlorothiazide; Valsartan | Tablet; Oral | SUPPL-2 | Zydus Lifesciences | Labeling | Approved |
Valsartan and Hydrochlorothiazide
ANDA #203000 |
Hydrochlorothiazide; Valsartan | Tablet; Oral | SUPPL-1 | Zydus Lifesciences | Labeling | Approved |
Valsartan and Hydrochlorothiazide
ANDA #203000 |
Hydrochlorothiazide; Valsartan | Tablet; Oral | SUPPL-2 | Zydus Lifesciences | Labeling | Approved |
Vasopressin
NDA #217766 |
Vasopressin | Injectable; Injection | ORIG-1 | Long Grove Pharms | Type 3 - New Dosage Form | Tentative Approval |
April 29, 2024
Drug Name and Application Number |
Active Ingredient | Dosage Form/ Route | Submission | Company | Submission Classification | Submission Status |
---|---|---|---|---|---|---|
Amoxicillin and Clavulanate Potassium
ANDA #065063 |
Amoxicillin; Clavulanate Potassium | Tablet; Oral | SUPPL-48 | Sandoz | Labeling | Approved |
Amoxicillin and Clavulanate Potassium
ANDA #065064 |
Amoxicillin; Clavulanate Potassium | Tablet; Oral | SUPPL-47 | Sandoz | Labeling | Approved |
Amoxicillin and Clavulanate Potassium
ANDA #065065 |
Amoxicillin; Clavulanate Potassium | Tablet, Chewable; Oral | SUPPL-34 | Sandoz | Labeling | Approved |
Amoxicillin and Clavulanate Potassium
ANDA #065066 |
Amoxicillin; Clavulanate Potassium | For Suspension; Oral | SUPPL-45 | Sandoz | Labeling | Approved |
Amoxicillin and Clavulanate Potassium
ANDA #065189 |
Amoxicillin; Clavulanate Potassium | Tablet; Oral | SUPPL-28 | Sandoz | Labeling | Approved |
Atropine Sulfate
ANDA #217791 |
Atropine Sulfate | Solution/Drops; Ophthalmic | ORIG-1 | Somerset | Approved | |
Besremi
BLA #761166 |
Ropeginterferon Alfa-2b-Njft | Injectable; Subcutaneous | SUPPL-7 | Pharmaessentia Corp | Labeling | Approved |
Colchicine
ANDA #210757 |
Colchicine | Capsule; Oral | ORIG-1 | Granules | Approved | |
Colchicine
ANDA #215463 |
Colchicine | Capsule; Oral | ORIG-1 | Aurobindo Pharma Ltd | Approved | |
Colchicine
ANDA #217620 |
Colchicine | Capsule; Oral | ORIG-1 | Annora Pharma | Approved | |
Ezetimibe
ANDA #211159 |
Ezetimibe | Tablet; Oral | ORIG-1 | Macleods Pharms Ltd | Approved | |
Givlaari
NDA #212194 |
Givosiran Sodium | Solution; Subcutaneous | SUPPL-7 | Alnylam Pharms Inc | Labeling | Approved |
Lanoxin
NDA #020405 |
Digoxin | Tablet; Oral | SUPPL-17 | Concordia | Labeling | Approved |
Lidocaine Hydrochloride
ANDA #218411 |
Lidocaine Hydrochloride | Solution; Topical | ORIG-1 | The J Molner | Approved | |
Lupkynis
NDA #213716 |
Voclosporin | Capsule; Oral | SUPPL-4 | Aurinia | Efficacy | Approved |
Lupkynis
NDA #213716 |
Voclosporin | Capsule; Oral | SUPPL-4 | Aurinia | Efficacy | Approved |
Lupkynis
NDA #213716 |
Voclosporin | Capsule; Oral | SUPPL-4 | Aurinia | Efficacy | Approved |
Midostaurin
ANDA #216076 |
Midostaurin | Capsule; Oral | ORIG-1 | Teva Pharms | Approved | |
Omvoh
BLA #761279 |
Mirikizumab-Mrkz | Injectable; Subcutaneous | SUPPL-1 | Eli Lilly and Co | Labeling | Approved |
Omvoh
BLA #761279 |
Mirikizumab-Mrkz | Injectable; Subcutaneous | SUPPL-1 | Eli Lilly and Co | Labeling | Approved |
Omvoh
BLA #761279 |
Mirikizumab-Mrkz | Injectable; Subcutaneous | SUPPL-1 | Eli Lilly and Co | Labeling | Approved |
Omvoh
BLA #761279 |
Mirikizumab-Mrkz | Vial; Single-Use | SUPPL-1 | Eli Lilly and Co | Labeling | Approved |
Omvoh
BLA #761279 |
Mirikizumab-Mrkz | Vial; Single-Use | SUPPL-1 | Eli Lilly and Co | Labeling | Approved |
Omvoh
BLA #761279 |
Mirikizumab-Mrkz | Vial; Single-Use | SUPPL-1 | Eli Lilly and Co | Labeling | Approved |
Tagrisso
NDA #208065 |
Osimertinib Mesylate | Tablet; Oral | SUPPL-31 | Astrazeneca | Labeling | Approved |
Tivdak
BLA #761208 |
Tisotumab Vedotin-Tftv | Injectable; Injection | SUPPL-7 | Seagen | Efficacy | Approved |
Tretinoin
ANDA #217804 |
Tretinoin | Cream; Topical | ORIG-1 | Alembic | Approved | |
Truvada
NDA #021752 |
Emtricitabine; Tenofovir Disoproxil Fumarate | Tablet; Oral | SUPPL-64 | Gilead | Labeling | Approved |
Truvada
NDA #021752 |
Emtricitabine; Tenofovir Disoproxil Fumarate | Tablet; Oral | SUPPL-64 | Gilead | Labeling | Approved |
April 26, 2024
Drug Name and Application Number |
Active Ingredient | Dosage Form/ Route | Submission | Company | Submission Classification | Submission Status |
---|---|---|---|---|---|---|
Acetaminophen and Ibuprofen
ANDA #218311 |
Acetaminophen; Ibuprofen | Tablet; Oral | ORIG-1 | Glenmark Pharms Ltd | Approved | |
Amoxicillin and Clavulanate Potassium
ANDA #065162 |
Amoxicillin; Clavulanate Potassium | For Suspension; Oral | SUPPL-36 | Teva | Labeling | Approved |
Amoxicillin and Clavulanate Potassium
ANDA #065162 |
Amoxicillin; Clavulanate Potassium | For Suspension; Oral | SUPPL-29 | Teva | Labeling | Approved |
Amoxicillin and Clavulanate Potassium
ANDA #065162 |
Amoxicillin; Clavulanate Potassium | For Suspension; Oral | SUPPL-32 | Teva | Labeling | Approved |
Amoxicillin and Clavulanate Potassium
ANDA #065162 |
Amoxicillin; Clavulanate Potassium | For Suspension; Oral | SUPPL-36 | Teva | Labeling | Approved |
Clindamycin Phosphate
ANDA #064050 |
Clindamycin Phosphate | Solution; Topical | SUPPL-24 | Padagis Us | Manufacturing (CMC) | Approved |
Clindamycin Phosphate
ANDA #064050 |
Clindamycin Phosphate | Solution; Topical | SUPPL-24 | Padagis Us | Manufacturing (CMC) | Approved |
Libervant
NDA #218623 |
Diazepam | Film; Buccal | ORIG-1 | Aquestive Therapeutics Inc | Type 9 - New Indication Submitted as Distinct NDA, Consolidated with Original NDA after Approval | Approved |
Rinvoq
NDA #211675 |
Upadacitinib | Tablet, Extended Release; Oral | SUPPL-21 | Abbvie | Efficacy | Approved |
Rinvoq
NDA #211675 |
Upadacitinib | Tablet, Extended Release; Oral | SUPPL-22 | Abbvie | Efficacy | Approved |
Rinvoq
NDA #218347 |
Upadacitinib | Tablet, Extended Release; Oral | ORIG-1 | Abbvie Inc | Type 3 - New Dosage Form | Approved |
Rinvoq Lq
NDA #218347 |
Upadacitinib | Solution; Oral | ORIG-1 | Abbvie Inc | Type 3 - New Dosage Form | Approved |
Xolremdi
NDA #218709 |
Mavorixafor | Capsule; Oral | ORIG-1 | X4 Pharmaceuticals Inc | Type 1 - New Molecular Entity | Approved |
Zilbrysq
NDA #216834 |
Zilucoplan Sodium | Solution; Subcutaneous | SUPPL-1 | Ucb Inc | Labeling | Approved |
April 25, 2024
Drug Name and Application Number |
Active Ingredient | Dosage Form/ Route | Submission | Company | Submission Classification | Submission Status |
---|---|---|---|---|---|---|
Amoxicillin
ANDA #062881 |
Amoxicillin | Capsule; Oral | SUPPL-26 | Strides Pharma | Labeling | Approved |
Amoxicillin
ANDA #062881 |
Amoxicillin | Capsule; Oral | SUPPL-27 | Strides Pharma | Labeling | Approved |
Amoxicillin
ANDA #062881 |
Amoxicillin | Capsule; Oral | SUPPL-28 | Strides Pharma | Labeling | Approved |
Amoxicillin
ANDA #062884 |
Amoxicillin | Capsule; Oral | SUPPL-24 | Strides Pharma | Labeling | Approved |
Amoxicillin
ANDA #062884 |
Amoxicillin | Capsule; Oral | SUPPL-23 | Strides Pharma | Labeling | Approved |
Amoxicillin
ANDA #062884 |
Amoxicillin | Capsule; Oral | SUPPL-24 | Strides Pharma | Labeling | Approved |
Amoxicillin
ANDA #062884 |
Amoxicillin | Capsule; Oral | SUPPL-25 | Strides Pharma | Labeling | Approved |
Amoxicillin
ANDA #064076 |
Amoxicillin | Capsule; Oral | SUPPL-37 | Sandoz | Labeling | Approved |
Amoxicillin
ANDA #064139 |
Amoxicillin | Tablet, Chewable; Oral | SUPPL-13 | Chartwell Rx | Labeling | Approved |
Amoxicillin
ANDA #064139 |
Amoxicillin | Tablet, Chewable; Oral | SUPPL-14 | Chartwell Rx | Labeling | Approved |
Amoxicillin
ANDA #064139 |
Amoxicillin | Tablet, Chewable; Oral | SUPPL-15 | Chartwell Rx | Labeling | Approved |
Amoxicillin
ANDA #065228 |
Amoxicillin | Tablet; Oral | SUPPL-17 | Sandoz | Labeling | Approved |
Amoxicillin
ANDA #065228 |
Amoxicillin | Tablet; Oral | SUPPL-17 | Sandoz | Labeling | Approved |
Amoxicillin
ANDA #065228 |
Amoxicillin | Tablet; Oral | SUPPL-19 | Sandoz | Labeling | Approved |
Amoxicillin
ANDA #065255 |
Amoxicillin | Tablet; Oral | SUPPL-25 | Hikma | Labeling | Approved |
Amoxicillin
ANDA #065325 |
Amoxicillin | For Suspension; Oral | SUPPL-32 | Hikma | Labeling | Approved |
Amoxicillin
ANDA #065344 |
Amoxicillin | Tablet; Oral | SUPPL-5 | Chartwell Rx | Labeling | Approved |
Amoxicillin
ANDA #065344 |
Amoxicillin | Tablet; Oral | SUPPL-6 | Chartwell Rx | Labeling | Approved |
Amoxicillin
ANDA #065344 |
Amoxicillin | Tablet; Oral | SUPPL-7 | Chartwell Rx | Labeling | Approved |
Amoxicillin
ANDA #065378 |
Amoxicillin | For Suspension; Oral | SUPPL-18 | Sandoz | Labeling | Approved |
Amoxicillin
ANDA #065387 |
Amoxicillin | For Suspension; Oral | SUPPL-18 | Sandoz | Labeling | Approved |
Amoxicillin and Clavulanate Potassium
ANDA #201090 |
Amoxicillin; Clavulanate Potassium | For Suspension; Oral | SUPPL-11 | Aurobindo Pharma Ltd | Labeling | Approved |
Amoxicillin and Clavulanate Potassium
ANDA #201090 |
Amoxicillin; Clavulanate Potassium | For Suspension; Oral | SUPPL-5 | Aurobindo Pharma Ltd | Labeling | Approved |
Amoxicillin and Clavulanate Potassium
ANDA #201090 |
Amoxicillin; Clavulanate Potassium | For Suspension; Oral | SUPPL-11 | Aurobindo Pharma Ltd | Labeling | Approved |
Amrix
NDA #021777 |
Cyclobenzaprine Hydrochloride | Capsule, Extended Release; Oral | SUPPL-19 | Teva Pharms Intl | Labeling | Approved |
Brinzolamide
ANDA #204884 |
Brinzolamide | Suspension/Drops; Ophthalmic | SUPPL-7 | Bausch and Lomb | Labeling | Approved |
Cetrorelix Acetate
ANDA #218150 |
Cetrorelix Acetate | Powder; Subcutaneous | ORIG-1 | Gland | Approved | |
Deflazacort
ANDA #217813 |
Deflazacort | Suspension; Oral | ORIG-1 | Tris Pharma Inc | Approved | |
Diazepam
ANDA #218450 |
Diazepam | Injectable; Injection | ORIG-1 | Alembic | Approved | |
Digoxin
NDA #021648 |
Digoxin | Elixir; Oral | SUPPL-15 | Hikma | Labeling | Approved |
Digoxin
NDA #021648 |
Digoxin | Elixir; Oral | SUPPL-15 | Hikma | Labeling | Approved |
Eslicarbazepine Acetate
ANDA #211247 |
Eslicarbazepine Acetate | Unknown | ORIG-1 | Sph Shanghai Zhongxi Pharma Co Ltd | Tentative Approval | |
Galzin
NDA #020458 |
Zinc Acetate | Capsule; Oral | SUPPL-9 | Teva | Labeling | Approved |
Hercessi
BLA #761346 |
Trastuzumab-Strf | Injectable; Injection | ORIG-1 | Accord Biopharma Inc. | Approved | |
Otezla
NDA #205437 |
Apremilast | Tablet; Oral | SUPPL-13 | Amgen Inc | Efficacy | Approved |
Safinamide Mesylate
ANDA #215739 |
Safinamide Mesylate | Tablet; Oral | ORIG-1 | Prinston Inc | Approved | |
Sevelamer Carbonate
ANDA #207291 |
Sevelamer Carbonate | For Suspension; Oral | ORIG-1 | Macleods Pharms Ltd | Approved | |
Trandate
NDA #018716 |
Labetalol Hydrochloride | Tablet; Oral | SUPPL-36 | Alvogen | Labeling | Approved |
Tretinoin
ANDA #218561 |
Tretinoin | Cream; Topical | ORIG-1 | Zydus Lifesciences | Approved | |
Viorele
ANDA #091346 |
Desogestrel; Ethinyl Estradiol | Tablet; Oral-28 | SUPPL-16 | Glenmark Pharms Ltd | Manufacturing (CMC) | Approved |
Zinc Chloride In Plastic Container
NDA #018959 |
Zinc Chloride | Injectable; Injection | SUPPL-32 | Hospira | Labeling | Approved |
May 2, 2024
Drug Name and Application Number | Active Ingredient | Dosage Form/ Route | Submission | Company | Submission Classification | Submission Status |
---|---|---|---|---|---|---|
Esmolol Hydrochloride Double Strength In Plastic Container
NDA #205703 |
Esmolol Hydrochloride | Solution; Intravenous | SUPPL-3 | Hq Spclt Pharma | Labeling | Approved |
Esmolol Hydrochloride In Plastic Container
NDA #205703 |
Esmolol Hydrochloride | Solution; Intravenous | SUPPL-3 | Hq Spclt Pharma | Labeling | Approved |
May 1, 2024
Drug Name and Application Number | Active Ingredient | Dosage Form/ Route | Submission | Company | Submission Classification | Submission Status |
---|---|---|---|---|---|---|
Amoxicillin
ANDA #061926 |
Amoxicillin | Capsule; Oral | SUPPL-136 | Teva | Labeling | Approved |
Amoxicillin
ANDA #061931 |
Amoxicillin | For Suspension; Oral | SUPPL-60 | Teva | Labeling | Approved |
Amoxicillin
ANDA #062058 |
Amoxicillin | Capsule; Oral | SUPPL-15 | Chartwell | Labeling | Approved |
Amoxicillin
ANDA #062059 |
Amoxicillin | For Suspension; Oral | SUPPL-6 | Chartwell Rx | Labeling | Approved |
Amoxicillin
ANDA #062881 |
Amoxicillin | Capsule; Oral | SUPPL-29 | Strides Pharma | Labeling | Approved |
Amoxicillin
ANDA #062884 |
Amoxicillin | Capsule; Oral | SUPPL-26 | Strides Pharma | Labeling | Approved |
Amoxicillin
ANDA #062927 |
Amoxicillin | For Suspension; Oral | SUPPL-29 | Dava Pharms Inc | Labeling | Approved |
Amoxicillin
ANDA #064013 |
Amoxicillin | Tablet, Chewable; Oral | SUPPL-64 | Teva | Labeling | Approved |
Amoxicillin
ANDA #064076 |
Amoxicillin | Capsule; Oral | SUPPL-38 | Sandoz | Labeling | Approved |
Amoxicillin
ANDA #064139 |
Amoxicillin | Tablet, Chewable; Oral | SUPPL-16 | Chartwell Rx | Labeling | Approved |
Amoxicillin
ANDA #065056 |
Amoxicillin | Tablet; Oral | SUPPL-26 | Teva | Labeling | Approved |
Amoxicillin
ANDA #065119 |
Amoxicillin | For Suspension; Oral | SUPPL-33 | Teva | Labeling | Approved |
Amoxicillin
ANDA #065228 |
Amoxicillin | Tablet; Oral | SUPPL-20 | Sandoz | Labeling | Approved |
Amoxicillin
ANDA #065255 |
Amoxicillin | Tablet; Oral | SUPPL-28 | Hikma | Labeling | Approved |
Amoxicillin
ANDA #065256 |
Amoxicillin | Tablet; Oral | SUPPL-25 | Aurobindo | Labeling | Approved |
Amoxicillin
ANDA #065271 |
Amoxicillin | Capsule; Oral | SUPPL-25 | Aurobindo | Labeling | Approved |
Amoxicillin
ANDA #065291 |
Amoxicillin | Capsule; Oral | SUPPL-33 | Hikma Pharms | Labeling | Approved |
Amoxicillin
ANDA #065322 |
Amoxicillin | For Suspension; Oral | SUPPL-39 | Hikma | Labeling | Approved |
Amoxicillin
ANDA #065325 |
Amoxicillin | For Suspension; Oral | SUPPL-35 | Hikma | Labeling | Approved |
Amoxicillin
ANDA #065334 |
Amoxicillin | For Suspension; Oral | SUPPL-25 | Aurobindo | Labeling | Approved |
Amoxicillin
ANDA #065344 |
Amoxicillin | Tablet; Oral | SUPPL-8 | Chartwell Rx | Labeling | Approved |
Amoxicillin
ANDA #065378 |
Amoxicillin | For Suspension; Oral | SUPPL-19 | Sandoz | Labeling | Approved |
Amoxicillin
ANDA #065387 |
Amoxicillin | For Suspension; Oral | SUPPL-19 | Sandoz | Labeling | Approved |
Amoxicillin
ANDA #204030 |
Amoxicillin | For Suspension; Oral | SUPPL-13 | Aurobindo Pharma Ltd | Labeling | Approved |
Amoxicillin
ANDA #207471 |
Amoxicillin | Capsule; Oral | SUPPL-2 | Micro Labs | Labeling | Approved |
Amoxicillin and Clavulanate Potassium
ANDA #065063 |
Amoxicillin; Clavulanate Potassium | Tablet; Oral | SUPPL-51 | Sandoz | Labeling | Approved |
Amoxicillin and Clavulanate Potassium
ANDA #065064 |
Amoxicillin; Clavulanate Potassium | Tablet; Oral | SUPPL-50 | Sandoz | Labeling | Approved |
Amoxicillin and Clavulanate Potassium
ANDA #065065 |
Amoxicillin; Clavulanate Potassium | Tablet, Chewable; Oral | SUPPL-35 | Sandoz | Labeling | Approved |
Amoxicillin and Clavulanate Potassium
ANDA #065066 |
Amoxicillin; Clavulanate Potassium | For Suspension; Oral | SUPPL-50 | Sandoz | Labeling | Approved |
Amoxicillin and Clavulanate Potassium
ANDA #065089 |
Amoxicillin; Clavulanate Potassium | For Suspension; Oral | SUPPL-30 | Teva | Labeling | Approved |
Amoxicillin and Clavulanate Potassium
ANDA #065093 |
Amoxicillin; Clavulanate Potassium | Tablet; Oral | SUPPL-33 | Sandoz Inc | Labeling | Approved |
Amoxicillin and Clavulanate Potassium
ANDA #065096 |
Amoxicillin; Clavulanate Potassium | Tablet; Oral | SUPPL-39 | Teva Pharms Usa | Labeling | Approved |
Amoxicillin and Clavulanate Potassium
ANDA #065096 |
Amoxicillin; Clavulanate Potassium | Tablet; Oral | SUPPL-39 | Teva Pharms Usa | Labeling | Approved |
Amoxicillin and Clavulanate Potassium
ANDA #065098 |
Amoxicillin; Clavulanate Potassium | For Suspension; Oral | SUPPL-25 | Sandoz Inc | Labeling | Approved |
Amoxicillin and Clavulanate Potassium
ANDA #065101 |
Amoxicillin; Clavulanate Potassium | Tablet; Oral | SUPPL-38 | Teva | Labeling | Approved |
Amoxicillin and Clavulanate Potassium
ANDA #065117 |
Amoxicillin; Clavulanate Potassium | Tablet; Oral | SUPPL-34 | Sandoz Inc | Labeling | Approved |
Amoxicillin and Clavulanate Potassium
ANDA #065162 |
Amoxicillin; Clavulanate Potassium | For Suspension; Oral | SUPPL-40 | Teva | Labeling | Approved |
Amoxicillin and Clavulanate Potassium
ANDA #065162 |
Amoxicillin; Clavulanate Potassium | For Suspension; Oral | SUPPL-40 | Teva | Labeling | Approved |
Amoxicillin and Clavulanate Potassium
ANDA #065189 |
Amoxicillin; Clavulanate Potassium | Tablet; Oral | SUPPL-30 | Sandoz | Labeling | Approved |
Amoxicillin and Clavulanate Potassium
ANDA #065191 |
Amoxicillin; Clavulanate Potassium | For Suspension; Oral | SUPPL-35 | Hikma Pharms | Labeling | Approved |
Amoxicillin and Clavulanate Potassium
ANDA #065205 |
Amoxicillin; Clavulanate Potassium | Tablet, Chewable; Oral | SUPPL-30 | Teva | Labeling | Approved |
Amoxicillin and Clavulanate Potassium
ANDA #065317 |
Amoxicillin; Clavulanate Potassium | Tablet; Oral | SUPPL-4 | Apotex Inc | Labeling | Approved |
Amoxicillin and Clavulanate Potassium
ANDA #065317 |
Amoxicillin; Clavulanate Potassium | Tablet; Oral | SUPPL-4 | Apotex Inc | Labeling | Approved |
Amoxicillin and Clavulanate Potassium
ANDA #065333 |
Amoxicillin; Clavulanate Potassium | Tablet; Oral | SUPPL-4 | Apotex Inc | Labeling | Approved |
Amoxicillin and Clavulanate Potassium
ANDA #065333 |
Amoxicillin; Clavulanate Potassium | Tablet; Oral | SUPPL-4 | Apotex Inc | Labeling | Approved |
Amoxicillin and Clavulanate Potassium
ANDA #065373 |
Amoxicillin; Clavulanate Potassium | For Suspension; Oral | SUPPL-27 | Hikma Pharms | Labeling | Approved |
Amoxicillin and Clavulanate Potassium
ANDA #065373 |
Amoxicillin; Clavulanate Potassium | For Suspension; Oral | SUPPL-23 | Hikma Pharms | Labeling | Approved |
Amoxicillin and Clavulanate Potassium
ANDA #065373 |
Amoxicillin; Clavulanate Potassium | For Suspension; Oral | SUPPL-27 | Hikma Pharms | Labeling | Approved |
Amoxicillin and Clavulanate Potassium
ANDA #065373 |
Amoxicillin; Clavulanate Potassium | For Suspension; Oral | SUPPL-30 | Hikma Pharms | Labeling | Approved |
Amoxicillin and Clavulanate Potassium
ANDA #090227 |
Amoxicillin; Clavulanate Potassium | Tablet, Extended Release; Oral | SUPPL-19 | Sandoz | Labeling | Approved |
Amoxicillin and Clavulanate Potassium
ANDA #201090 |
Amoxicillin; Clavulanate Potassium | For Suspension; Oral | SUPPL-14 | Aurobindo Pharma Ltd | Labeling | Approved |
Amoxicillin and Clavulanate Potassium
ANDA #201091 |
Amoxicillin; Clavulanate Potassium | For Suspension; Oral | SUPPL-13 | Aurobindo Pharma Ltd | Labeling | Approved |
Amoxicillin and Clavulanate Potassium
ANDA #204755 |
Amoxicillin; Clavulanate Potassium | Tablet; Oral | SUPPL-12 | Micro Labs Ltd India | Labeling | Approved |
Amoxicillin and Clavulanate Potassium
ANDA #205187 |
Amoxicillin; Clavulanate Potassium | For Suspension; Oral | SUPPL-4 | Micro Labs Ltd India | Labeling | Approved |
Amoxicillin and Clavulanate Potassium
ANDA #205707 |
Amoxicillin; Clavulanate Potassium | Tablet; Oral | SUPPL-12 | Micro Labs Ltd India | Labeling | Approved |
Amoxicillin Pediatric
ANDA #061931 |
Amoxicillin | For Suspension; Oral | SUPPL-60 | Teva | Labeling | Approved |
Amoxil
NDA #050542 |
Amoxicillin | Tablet, Chewable; Oral | SUPPL-32 | Us Antibiotics | Labeling | Approved |
Amoxil
NDA #050754 |
Amoxicillin | Tablet; Oral | SUPPL-22 | Us Antibiotics | Labeling | Approved |
Amoxil
NDA #050760 |
Amoxicillin | For Suspension; Oral | SUPPL-23 | Us Antibiotics | Labeling | Approved |
Amoxil
NDA #050761 |
Amoxicillin | Tablet, Chewable; Oral | SUPPL-19 | Us Antibiotics | Labeling | Approved |
Amoxil
ANDA #062216 |
Amoxicillin | Capsule; Oral | SUPPL-44 | Us Antibiotics | Labeling | Approved |
Amoxil
ANDA #062216 |
Amoxicillin | Capsule; Oral | SUPPL-44 | Us Antibiotics | Labeling | Approved |
Amoxil
ANDA #062226 |
Amoxicillin | For Suspension; Oral | SUPPL-40 | Us Antibiotics | Labeling | Approved |
Ampicillin Sodium
ANDA #061395 |
Ampicillin Sodium | Injectable; Injection | SUPPL-52 | Sandoz | Labeling | Approved |
Ampicillin Sodium
ANDA #062692 |
Ampicillin Sodium | Injectable; Injection | SUPPL-2 | Hikma | Labeling | Approved |
Ampicillin Sodium
ANDA #062719 |
Ampicillin Sodium | Injectable; Injection | SUPPL-16 | Istituto Bio Ita Spa | Labeling | Approved |
Ampicillin Sodium
ANDA #062738 |
Ampicillin Sodium | Powder; Intravenous | SUPPL-33 | Sandoz | Labeling | Approved |
Ampicillin Sodium
ANDA #062772 |
Ampicillin Sodium | Injectable; Injection | SUPPL-17 | Hq Speclt Pharma | Labeling | Approved |
Ampicillin Sodium
ANDA #062797 |
Ampicillin Sodium | Injectable; Injection | SUPPL-13 | Istituto Bio Ita Spa | Labeling | Approved |
Ampicillin Sodium
ANDA #063142 |
Ampicillin Sodium | Injectable; Injection | SUPPL-18 | Hq Speclt Pharma | Labeling | Approved |
Ampicillin Sodium
ANDA #065493 |
Ampicillin Sodium | Injectable; Injection | SUPPL-11 | Eugia Pharma Speclts | Labeling | Approved |
Ampicillin Sodium
ANDA #065499 |
Ampicillin Sodium | Injectable; Injection | SUPPL-13 | Eugia Pharma Speclts | Labeling | Approved |
Ampicillin Sodium
ANDA #090354 |
Ampicillin Sodium | Injectable; Injection | SUPPL-7 | Antibiotice | Labeling | Approved |
Ampicillin Sodium
ANDA #090581 |
Ampicillin Sodium | Injectable; Injection | SUPPL-5 | Sagent Pharms Inc | Labeling | Approved |
Ampicillin Sodium
ANDA #090583 |
Ampicillin Sodium | Injectable; Injection | SUPPL-5 | Sagent Pharms Inc | Labeling | Approved |
Ampicillin Sodium
ANDA #090884 |
Ampicillin Sodium | Injectable; Injection | SUPPL-3 | Acs Dobfar Spa | Labeling | Approved |
Ampicillin Sodium
ANDA #090889 |
Ampicillin Sodium | Injectable; Injection | SUPPL-3 | Acs Dobfar Spa | Labeling | Approved |
Ampicillin Sodium
ANDA #201025 |
Ampicillin Sodium | Injectable; Injection | SUPPL-10 | Steriscience | Labeling | Approved |
Ampicillin Sodium
ANDA #201404 |
Ampicillin Sodium | Injectable; Injection | SUPPL-8 | Istituto Bio Ita Spa | Labeling | Approved |
Ampicillin Sodium
ANDA #202198 |
Ampicillin Sodium | Injectable; Injection | SUPPL-7 | Steriscience | Labeling | Approved |
Ampicillin Trihydrate
ANDA #061502 |
Ampicillin/Ampicillin Trihydrate | Capsule; Oral | SUPPL-140 | Chartwell Rx | Labeling | Approved |
Ampicillin Trihydrate
ANDA #062882 |
Ampicillin/Ampicillin Trihydrate | Capsule; Oral | SUPPL-17 | Strides Pharma | Labeling | Approved |
Ampicillin Trihydrate
ANDA #062883 |
Ampicillin/Ampicillin Trihydrate | Capsule; Oral | SUPPL-15 | Strides Pharma | Labeling | Approved |
Ampicillin Trihydrate
ANDA #062982 |
Ampicillin/Ampicillin Trihydrate | For Suspension; Oral | SUPPL-16 | Dava Pharms Inc | Labeling | Approved |
Ampicillin Trihydrate
ANDA #064082 |
Ampicillin/Ampicillin Trihydrate | Capsule; Oral | SUPPL-22 | Sandoz | Labeling | Approved |
Ampicillin Trihydrate
ANDA #216554 |
Ampicillin/Ampicillin Trihydrate | Capsule; Oral | SUPPL-1 | Aurobindo Pharma | Labeling | Approved |
Augmentin '125'
NDA #050575 |
Amoxicillin; Clavulanate Potassium | For Suspension; Oral | SUPPL-51 | Us Antibiotics | Labeling | Approved |
Augmentin '125'
NDA #050597 |
Amoxicillin; Clavulanate Potassium | Tablet, Chewable; Oral | SUPPL-52 | Us Antibiotics | Labeling | Approved |
Augmentin '200'
NDA #050725 |
Amoxicillin; Clavulanate Potassium | For Suspension; Oral | SUPPL-36 | Us Antibiotics | Labeling | Approved |
Augmentin '200'
NDA #050726 |
Amoxicillin; Clavulanate Potassium | Tablet, Chewable; Oral | SUPPL-27 | Us Antibiotics | Labeling | Approved |
Augmentin '250'
NDA #050564 |
Amoxicillin; Clavulanate Potassium | Tablet; Oral | SUPPL-60 | Us Antibiotics | Labeling | Approved |
Augmentin '250'
NDA #050575 |
Amoxicillin; Clavulanate Potassium | For Suspension; Oral | SUPPL-51 | Us Antibiotics | Labeling | Approved |
Augmentin '250'
NDA #050597 |
Amoxicillin; Clavulanate Potassium | Tablet, Chewable; Oral | SUPPL-52 | Us Antibiotics | Labeling | Approved |
Augmentin '400'
NDA #050725 |
Amoxicillin; Clavulanate Potassium | For Suspension; Oral | SUPPL-36 | Us Antibiotics | Labeling | Approved |
Augmentin '400'
NDA #050726 |
Amoxicillin; Clavulanate Potassium | Tablet, Chewable; Oral | SUPPL-27 | Us Antibiotics | Labeling | Approved |
Augmentin '500'
NDA #050564 |
Amoxicillin; Clavulanate Potassium | Tablet; Oral | SUPPL-60 | Us Antibiotics | Labeling | Approved |
Augmentin '875'
NDA #050720 |
Amoxicillin; Clavulanate Potassium | Tablet; Oral | SUPPL-37 | Us Antibiotics | Labeling | Approved |
Augmentin Es-600
NDA #050755 |
Amoxicillin; Clavulanate Potassium | For Suspension; Oral | SUPPL-29 | Us Antibiotics | Labeling | Approved |
Augmentin Xr
NDA #050785 |
Amoxicillin; Clavulanate Potassium | Tablet, Extended Release; Oral | SUPPL-18 | Us Antibiotics | Labeling | Approved |
Dexmedetomidine Hydrochloride
ANDA #203972 |
Dexmedetomidine Hydrochloride | Injectable; Injection | SUPPL-14 | Par Sterile Products | Labeling | Approved |
Dexmedetomidine Hydrochloride
ANDA #203972 |
Dexmedetomidine Hydrochloride | Injectable; Injection | SUPPL-15 | Par Sterile Products | Labeling | Approved |
Dexmedetomidine Hydrochloride
ANDA #208266 |
Dexmedetomidine Hydrochloride | Injectable; Injection | SUPPL-9 | Par Sterile Products | Labeling | Approved |
Etodolac
ANDA #204729 |
Etodolac | Tablet; Oral | ORIG-1 | Ipca Labs Ltd | Approved | |
Lansoprazole, Amoxicillin and Clarithromycin (Copackaged)
ANDA #200218 |
Amoxicillin; Clarithromycin; Lansoprazole | Capsule, Tablet, Capsule, Delayed Rel Pellets; Oral | SUPPL-12 | Ani Pharms | Labeling | Approved |
Larotid
ANDA #062226 |
Amoxicillin | For Suspension; Oral | SUPPL-40 | Us Antibiotics | Labeling | Approved |
Memantine;Donepezil Hydrochlorides
ANDA #216901 |
Memantine;Donepezil Hydrochlorides | Capsule, Extended Release; Oral | ORIG-1 | Xiamen Lp Pharm Co | Tentative Approval | |
Moxatag
NDA #050813 |
Amoxicillin | Tablet, Extended Release; Oral | SUPPL-10 | Pragma | Labeling | Approved |
Mycophenolate Mofetil
ANDA #212634 |
Mycophenolate Mofetil | For Suspension; Oral | SUPPL-1 | Strides Pharma | Labeling | Approved |
Mycophenolate Mofetil
ANDA #212634 |
Mycophenolate Mofetil | For Suspension; Oral | SUPPL-1 | Strides Pharma | Labeling | Approved |
Myhibbin
NDA #216482 |
Mycophenolate Mofetil | Suspension; Oral | ORIG-1 | Azurity Pharmaceuticals Inc | Type 5 - New Formulation or New Manufacturer | Approved |
Omeprazole and Clarithromycin and Amoxicillin
NDA #050824 |
Amoxicillin; Clarithromycin; Omeprazole | Capsule, Tablet, Capsule, Delayed Release; Oral | SUPPL-13 | Cumberland | Labeling | Approved |
Oseltamivir Phosphate
ANDA #218565 |
Oseltamivir Phosphate | Capsule; Oral | ORIG-1 | Laurus | Approved | |
Oxymorphone Hydrochloride
ANDA #204459 |
Oxymorphone Hydrochloride | Tablet; Oral | SUPPL-7 | Aurolife Pharma Llc | Labeling | Approved |
Oxymorphone Hydrochloride
ANDA #204459 |
Oxymorphone Hydrochloride | Tablet; Oral | SUPPL-8 | Aurolife Pharma Llc | Labeling | Approved |
Oxymorphone Hydrochloride
ANDA #204459 |
Oxymorphone Hydrochloride | Tablet; Oral | SUPPL-9 | Aurolife Pharma Llc | Labeling | Approved |
Oxymorphone Hydrochloride
ANDA #204459 |
Oxymorphone Hydrochloride | Tablet; Oral | SUPPL-10 | Aurolife Pharma Llc | Labeling | Approved |
Oxymorphone Hydrochloride
ANDA #204459 |
Oxymorphone Hydrochloride | Tablet; Oral | SUPPL-7 | Aurolife Pharma Llc | Labeling | Approved |
Oxymorphone Hydrochloride
ANDA #204459 |
Oxymorphone Hydrochloride | Tablet; Oral | SUPPL-8 | Aurolife Pharma Llc | Labeling | Approved |
Oxymorphone Hydrochloride
ANDA #204459 |
Oxymorphone Hydrochloride | Tablet; Oral | SUPPL-9 | Aurolife Pharma Llc | Labeling | Approved |
Oxymorphone Hydrochloride
ANDA #204459 |
Oxymorphone Hydrochloride | Tablet; Oral | SUPPL-10 | Aurolife Pharma Llc | Labeling | Approved |
Piperacillin
ANDA #065114 |
Piperacillin Sodium | Injectable; Injection | SUPPL-18 | Istituto Bio Ita Spa | Labeling | Approved |
Piperacillin
ANDA #065157 |
Piperacillin Sodium | Injectable; Injection | SUPPL-15 | Istituto Bio Ita Spa | Labeling | Approved |
Piperacillin and Tazobactam
ANDA #065362 |
Piperacillin Sodium; Tazobactam Sodium | Injectable; Injection | SUPPL-44 | Sandoz | Labeling | Approved |
Piperacillin and Tazobactam
ANDA #065363 |
Piperacillin Sodium; Tazobactam Sodium | Injectable; Injection | SUPPL-47 | Sandoz | Labeling | Approved |
Piperacillin and Tazobactam
ANDA #065458 |
Piperacillin Sodium; Tazobactam Sodium | Injectable; Injection | SUPPL-16 | Steriscience | Labeling | Approved |
Piperacillin and Tazobactam
ANDA #065498 |
Piperacillin Sodium; Tazobactam Sodium | Injectable; Injection | SUPPL-26 | Eugia Pharma Speclts | Labeling | Approved |
Piperacillin and Tazobactam
ANDA #065523 |
Piperacillin Sodium; Tazobactam Sodium | Injectable; Injection | SUPPL-30 | Istituto Bio Ita Spa | Labeling | Approved |
Piperacillin and Tazobactam
ANDA #090498 |
Piperacillin Sodium; Tazobactam Sodium | Injectable; Injection | SUPPL-24 | Istituto Bio Ita Spa | Labeling | Approved |
Piperacillin and Tazobactam
ANDA #203557 |
Piperacillin Sodium; Tazobactam Sodium | Injectable; Injection | SUPPL-35 | Sandoz | Labeling | Approved |
Piperacillin and Tazobactam
ANDA #203719 |
Piperacillin Sodium; Tazobactam Sodium | Injectable; Injection | SUPPL-12 | Fresenius Kabi | Labeling | Approved |
Piperacillin and Tazobactam
ANDA #203720 |
Piperacillin Sodium; Tazobactam Sodium | Injectable; Injection | SUPPL-11 | Fresenius Kabi | Labeling | Approved |
Piperacillin and Tazobactam
ANDA #204959 |
Piperacillin Sodium; Tazobactam Sodium | Injectable; Injection | SUPPL-13 | Shandong | Labeling | Approved |
Piperacillin and Tazobactam
ANDA #206996 |
Piperacillin Sodium; Tazobactam Sodium | Injectable; Injection | SUPPL-9 | Wockhardt Bio Ag | Labeling | Approved |
Piperacillin and Tazobactam
ANDA #207146 |
Piperacillin Sodium; Tazobactam Sodium | Injectable; Injection | SUPPL-9 | Wockhardt Bio Ag | Labeling | Approved |
Piperacillin and Tazobactam
ANDA #207847 |
Piperacillin Sodium; Tazobactam Sodium | Injectable; Injection | SUPPL-15 | Provepharm Sas | Labeling | Approved |
Piperacillin and Tazobactam
ANDA #207848 |
Piperacillin Sodium; Tazobactam Sodium | Injectable; Injection | SUPPL-15 | Provepharm Sas | Labeling | Approved |
Piperacillin and Tazobactam
ANDA #208674 |
Piperacillin Sodium; Tazobactam Sodium | Injectable; Injection | SUPPL-5 | Sagent Pharms Inc | Labeling | Approved |
Piperacillin and Tazobactam
ANDA #208675 |
Piperacillin Sodium; Tazobactam Sodium | Injectable; Injection | SUPPL-5 | Sagent Pharms Inc | Labeling | Approved |
Piperacillin and Tazobactam
ANDA #217243 |
Piperacillin Sodium; Tazobactam Sodium | Injectable; Injection | SUPPL-4 | Shandong | Labeling | Approved |
Piperacillin and Tazobactam
ANDA #217409 |
Piperacillin Sodium; Tazobactam Sodium | Injectable; Injection | SUPPL-1 | Eugia Pharma | Labeling | Approved |
Piperacillin and Tazobactam
ANDA #217409 |
Piperacillin,Tazobactam | Injection; Powder,For Solution | SUPPL-1 | Eugia Pharma | Labeling | Approved |
Probampacin
ANDA #061741 |
Ampicillin/Ampicillin Trihydrate; Probenecid | For Suspension; Oral | SUPPL-1 | Cosette | Labeling | Approved |
Sugammadex
ANDA #214230 |
Sugammadex | Injectable; Injection | ORIG-1 | Mankind Pharma | Tentative Approval | |
Talicia
NDA #213004 |
Amoxicillin; Omeprazole Magnesium; Rifabutin | Capsule, Delayed Release; Oral | SUPPL-14 | Redhill | Labeling | Approved |
Unasyn
NDA #050608 |
Ampicillin Sodium; Sulbactam Sodium | Injectable; Injection | SUPPL-53 | Pfizer | Labeling | Approved |
Voquezna Dual Pak
NDA #215153 |
Amoxicillin; Vonoprazan Fumarate | Capsule, Tablet; Oral | SUPPL-7 | Phathom | Labeling | Approved |
Voquezna Triple Pak
NDA #215152 |
Amoxicillin; Clarithromycin; Vonoprazan Fumarate | Capsule, Tablet, Tablet; Oral | SUPPL-7 | Phathom | Labeling | Approved |
Zosyn
NDA #050684 |
Piperacillin Sodium; Tazobactam Sodium | Injectable; Injection | SUPPL-104 | Wyeth Pharms | Labeling | Approved |
Zosyn In Plastic Container
NDA #050750 |
Piperacillin Sodium; Tazobactam Sodium | Injectable; Injection | SUPPL-51 | Baxter Hlthcare Corp | Labeling | Approved |
April 30, 2024
Drug Name and Application Number | Active Ingredient | Dosage Form/ Route | Submission | Company | Submission Classification | Submission Status |
---|---|---|---|---|---|---|
Abrilada
BLA #761118 |
Adalimumab-Afzb | Injectable; Injection | SUPPL-12 | Pfizer Inc | Labeling | Approved |
Abrilada
BLA #761118 |
Adalimumab-Afzb | Injectable; Injection | SUPPL-12 | Pfizer Inc | Labeling | Approved |
Amoxicillin and Clavulanate Potassium
ANDA #090227 |
Amoxicillin; Clavulanate Potassium | Tablet, Extended Release; Oral | SUPPL-18 | Sandoz | Labeling | Approved |
Amoxicillin and Clavulanate Potassium
ANDA #090227 |
Amoxicillin; Clavulanate Potassium | Tablet, Extended Release; Oral | SUPPL-18 | Sandoz | Labeling | Approved |
Aranesp
BLA #103951 |
Darbepoetin Alfa | Vial; Intravenous | SUPPL-5383 | Amgen | Labeling | Approved |
Aranesp
BLA #103951 |
Darbepoetin Alfa | Vial; Intravenous | SUPPL-5383 | Amgen | Labeling | Approved |
Aranesp
BLA #103951 |
Darbepoetin Alfa | Vial; Subcutaneous | SUPPL-5383 | Amgen | Labeling | Approved |
Aranesp
BLA #103951 |
Darbepoetin Alfa | Vial; Subcutaneous | SUPPL-5383 | Amgen | Labeling | Approved |
Bromfenac Sodium
ANDA #210962 |
Bromfenac Sodium | Unknown | ORIG-1 | Amneal Pharms Co | Tentative Approval | |
Camzyos
NDA #214998 |
Mavacamten | Capsule; Oral | SUPPL-9 | Bristol | Labeling | Approved |
Cupric Chloride
ANDA #216113 |
Cupric Chloride | Injectable; Injection | ORIG-1 | Somerset | Approved | |
Cupric Chloride
ANDA #217626 |
Cupric Chloride | Injectable; Injection | ORIG-1 | Stira | Approved | |
Cyltezo
BLA #761058 |
Adalimumab-Adbm | Injectable; Injection | SUPPL-26 | Boehringer Ingelheim | Efficacy | Approved |
Dimethyl Fumarate
ANDA #210531 |
Dimethyl Fumarate | Capsule, Delayed Release; Oral | SUPPL-3 | Mylan | Labeling | Approved |
Dimethyl Fumarate
ANDA #210531 |
Dimethyl Fumarate | Capsule, Delayed Release; Oral | SUPPL-6 | Mylan | Labeling | Approved |
Dimethyl Fumarate
ANDA #210531 |
Dimethyl Fumarate | Capsule, Delayed Release; Oral | SUPPL-10 | Mylan | Labeling | Approved |
Dimethyl Fumarate
ANDA #210531 |
Dimethyl Fumarate | Capsule, Delayed Release; Oral | SUPPL-12 | Mylan | Labeling | Approved |
Dimethyl Fumarate
ANDA #210531 |
Dimethyl Fumarate | Capsule, Delayed Release; Oral | SUPPL-3 | Mylan | Labeling | Approved |
Dimethyl Fumarate
ANDA #210531 |
Dimethyl Fumarate | Capsule, Delayed Release; Oral | SUPPL-6 | Mylan | Labeling | Approved |
Dimethyl Fumarate
ANDA #210531 |
Dimethyl Fumarate | Capsule, Delayed Release; Oral | SUPPL-10 | Mylan | Labeling | Approved |
Dimethyl Fumarate
ANDA #210531 |
Dimethyl Fumarate | Capsule, Delayed Release; Oral | SUPPL-12 | Mylan | Labeling | Approved |
Dimethyl Fumarate
ANDA #210531 |
Dimethyl Fumarate | Capsule, Delayed Release; Oral | SUPPL-13 | Mylan | Labeling | Approved |
Dofetilide
ANDA #212750 |
Dofetilide | Capsule; Oral | SUPPL-2 | Granules | Labeling | Approved |
Dofetilide
ANDA #212750 |
Dofetilide | Capsule; Oral | SUPPL-2 | Granules | Labeling | Approved |
Dofetilide
ANDA #212750 |
Dofetilide | Capsule; Oral | SUPPL-2 | Granules | Labeling | Approved |
Epogen/Procrit
BLA #103234 |
Epoetin Alfa | Vial; Multidose | SUPPL-5378 | Amgen | Labeling | Approved |
Epogen/Procrit
BLA #103234 |
Epoetin Alfa | Vial; Multidose | SUPPL-5378 | Amgen | Labeling | Approved |
Epogen/Procrit
BLA #103234 |
Epoetin Alfa | Vial; Single-Use | SUPPL-5378 | Amgen | Labeling | Approved |
Epogen/Procrit
BLA #103234 |
Epoetin Alfa | Vial; Single-Use | SUPPL-5378 | Amgen | Labeling | Approved |
Esomeprazole Magnesium
ANDA #207198 |
Esomeprazole Magnesium | Capsule, Delayed Release; Oral | ORIG-1 | Dr Reddys | Approved | |
Everolimus
ANDA #206133 |
Everolimus | Tablet; Oral | SUPPL-6 | Hikma | Labeling | Approved |
Ezetimibe
ANDA #207311 |
Ezetimibe | Tablet; Oral | SUPPL-12 | Ohm Labs Inc | Labeling | Approved |
Hydrochlorothiazide
ANDA #202556 |
Hydrochlorothiazide | Tablet; Oral | SUPPL-8 | Accord Hlthcare | Labeling | Approved |
Hydrochlorothiazide
ANDA #203561 |
Hydrochlorothiazide | Capsule; Oral | SUPPL-3 | Sciegen Pharms Inc | Labeling | Approved |
Hydrochlorothiazide
ANDA #203561 |
Hydrochlorothiazide | Capsule; Oral | SUPPL-5 | Sciegen Pharms Inc | Labeling | Approved |
Hydrocortisone Butyrate
ANDA #209556 |
Hydrocortisone Butyrate | Lotion; Topical | SUPPL-4 | The J Molner | Labeling | Approved |
Hydrocortisone Butyrate
ANDA #209556 |
Hydrocortisone Butyrate | Lotion; Topical | SUPPL-4 | The J Molner | Labeling | Approved |
Ingrezza Sprinkle
NDA #218390 |
Valbenazine | Capsule; Oral | ORIG-1 | Neurocrine | Approved | |
Linezolid
ANDA #204536 |
Linezolid | Tablet; Oral | SUPPL-7 | Amneal Pharms | Labeling | Approved |
Linezolid
ANDA #204536 |
Linezolid | Tablet; Oral | SUPPL-8 | Amneal Pharms | Labeling | Approved |
Linezolid
ANDA #204536 |
Linezolid | Tablet; Oral | SUPPL-9 | Amneal Pharms | Labeling | Approved |
Losartan Potassium and Hydrochlorothiazide
ANDA #201845 |
Hydrochlorothiazide; Losartan Potassium | Tablet; Oral | SUPPL-20 | Jubilant Cadista | Labeling | Approved |
Losartan Potassium and Hydrochlorothiazide
ANDA #201845 |
Hydrochlorothiazide; Losartan Potassium | Tablet; Oral | SUPPL-20 | Jubilant Cadista | Labeling | Approved |
Meperidine Hydrochloride
ANDA #040186 |
Meperidine Hydrochloride | Tablet; Oral | SUPPL-13 | Watson Labs | Labeling | Approved |
Meperidine Hydrochloride
ANDA #040186 |
Meperidine Hydrochloride | Tablet; Oral | SUPPL-13 | Watson Labs | Labeling | Approved |
Meperidine Hydrochloride
ANDA #080448 |
Meperidine Hydrochloride | Tablet; Oral | SUPPL-23 | Sun Pharm Industries | Labeling | Approved |
Meperidine Hydrochloride
ANDA #080448 |
Meperidine Hydrochloride | Tablet; Oral | SUPPL-23 | Sun Pharm Industries | Labeling | Approved |
Mircera
BLA #125164 |
Methoxy Polyethylene Glycol-Epoetin Beta | Solution; Injection | SUPPL-89 | Hoffman-La Roche | Efficacy | Approved |
Myfembree
NDA #214846 |
Estradiol; Norethindrone Acetate; Relugolix | Tablet; Oral | SUPPL-7 | Myovant Sciences | Efficacy | Approved |
Nicorette
NDA #022360 |
Nicotine Polacrilex | Troche/Lozenge; Oral | SUPPL-17 | Haleon Us Holdings | Labeling | Approved |
Nicotine Polacrilex
ANDA #076778 |
Nicotine Polacrilex | Gum, Chewing; Buccal | SUPPL-19 | L Perrigo Co | Labeling | Approved |
Nicotine Polacrilex
ANDA #076778 |
Nicotine Polacrilex | Gum, Chewing; Buccal | SUPPL-19 | L Perrigo Co | Labeling | Approved |
Norethindrone Acetate and Ethinyl Estradiol and Ferrous Fumarate
ANDA #202742 |
Ethinyl Estradiol; Norethindrone Acetate | Tablet; Oral | SUPPL-10 | Mylan Labs Ltd | Labeling | Approved |
Norethindrone Acetate and Ethinyl Estradiol and Ferrous Fumarate
ANDA #202742 |
Ethinyl Estradiol; Norethindrone Acetate | Tablet; Oral | SUPPL-12 | Mylan Labs Ltd | Labeling | Approved |
Pitavastatin Calcium
ANDA #205977 |
Pitavastatin Calcium | Tablet; Oral | ORIG-1 | Hetero Labs Ltd V | Approved | |
Sevelamer Carbonate
ANDA #207179 |
Sevelamer Carbonate | Tablet; Oral | SUPPL-11 | Aurobindo Pharma | Labeling | Approved |
Sotalol Hydrochloride
ANDA #077616 |
Sotalol Hydrochloride | Tablet; Oral | SUPPL-8 | Aurobindo Pharma Usa | Labeling | Approved |
Sotalol Hydrochloride
ANDA #077616 |
Sotalol Hydrochloride | Tablet; Oral | SUPPL-5 | Aurobindo Pharma Usa | Labeling | Approved |
Sotalol Hydrochloride
ANDA #077616 |
Sotalol Hydrochloride | Tablet; Oral | SUPPL-8 | Aurobindo Pharma Usa | Labeling | Approved |
Ursodiol
ANDA #075517 |
Ursodiol | Capsule; Oral | SUPPL-18 | Epic Pharma | Labeling | Approved |
Valsartan and Hydrochlorothiazide
ANDA #201662 |
Hydrochlorothiazide; Valsartan | Tablet; Oral | SUPPL-26 | Alembic | Labeling | Approved |
Valsartan and Hydrochlorothiazide
ANDA #201662 |
Hydrochlorothiazide; Valsartan | Tablet; Oral | SUPPL-26 | Alembic | Labeling | Approved |
Valsartan and Hydrochlorothiazide
ANDA #203000 |
Hydrochlorothiazide; Valsartan | Tablet; Oral | SUPPL-1 | Zydus Lifesciences | Labeling | Approved |
Valsartan and Hydrochlorothiazide
ANDA #203000 |
Hydrochlorothiazide; Valsartan | Tablet; Oral | SUPPL-2 | Zydus Lifesciences | Labeling | Approved |
Valsartan and Hydrochlorothiazide
ANDA #203000 |
Hydrochlorothiazide; Valsartan | Tablet; Oral | SUPPL-1 | Zydus Lifesciences | Labeling | Approved |
Valsartan and Hydrochlorothiazide
ANDA #203000 |
Hydrochlorothiazide; Valsartan | Tablet; Oral | SUPPL-2 | Zydus Lifesciences | Labeling | Approved |
Vasopressin
NDA #217766 |
Vasopressin | Injectable; Injection | ORIG-1 | Long Grove Pharms | Type 3 - New Dosage Form | Tentative Approval |
April 29, 2024
Drug Name and Application Number | Active Ingredient | Dosage Form/ Route | Submission | Company | Submission Classification | Submission Status |
---|---|---|---|---|---|---|
Amoxicillin and Clavulanate Potassium
ANDA #065063 |
Amoxicillin; Clavulanate Potassium | Tablet; Oral | SUPPL-48 | Sandoz | Labeling | Approved |
Amoxicillin and Clavulanate Potassium
ANDA #065064 |
Amoxicillin; Clavulanate Potassium | Tablet; Oral | SUPPL-47 | Sandoz | Labeling | Approved |
Amoxicillin and Clavulanate Potassium
ANDA #065065 |
Amoxicillin; Clavulanate Potassium | Tablet, Chewable; Oral | SUPPL-34 | Sandoz | Labeling | Approved |
Amoxicillin and Clavulanate Potassium
ANDA #065066 |
Amoxicillin; Clavulanate Potassium | For Suspension; Oral | SUPPL-45 | Sandoz | Labeling | Approved |
Amoxicillin and Clavulanate Potassium
ANDA #065189 |
Amoxicillin; Clavulanate Potassium | Tablet; Oral | SUPPL-28 | Sandoz | Labeling | Approved |
Atropine Sulfate
ANDA #217791 |
Atropine Sulfate | Solution/Drops; Ophthalmic | ORIG-1 | Somerset | Approved | |
Besremi
BLA #761166 |
Ropeginterferon Alfa-2b-Njft | Injectable; Subcutaneous | SUPPL-7 | Pharmaessentia Corp | Labeling | Approved |
Colchicine
ANDA #210757 |
Colchicine | Capsule; Oral | ORIG-1 | Granules | Approved | |
Colchicine
ANDA #215463 |
Colchicine | Capsule; Oral | ORIG-1 | Aurobindo Pharma Ltd | Approved | |
Colchicine
ANDA #217620 |
Colchicine | Capsule; Oral | ORIG-1 | Annora Pharma | Approved | |
Ezetimibe
ANDA #211159 |
Ezetimibe | Tablet; Oral | ORIG-1 | Macleods Pharms Ltd | Approved | |
Givlaari
NDA #212194 |
Givosiran Sodium | Solution; Subcutaneous | SUPPL-7 | Alnylam Pharms Inc | Labeling | Approved |
Lanoxin
NDA #020405 |
Digoxin | Tablet; Oral | SUPPL-17 | Concordia | Labeling | Approved |
Lidocaine Hydrochloride
ANDA #218411 |
Lidocaine Hydrochloride | Solution; Topical | ORIG-1 | The J Molner | Approved | |
Lupkynis
NDA #213716 |
Voclosporin | Capsule; Oral | SUPPL-4 | Aurinia | Efficacy | Approved |
Lupkynis
NDA #213716 |
Voclosporin | Capsule; Oral | SUPPL-4 | Aurinia | Efficacy | Approved |
Lupkynis
NDA #213716 |
Voclosporin | Capsule; Oral | SUPPL-4 | Aurinia | Efficacy | Approved |
Midostaurin
ANDA #216076 |
Midostaurin | Capsule; Oral | ORIG-1 | Teva Pharms | Approved | |
Omvoh
BLA #761279 |
Mirikizumab-Mrkz | Injectable; Subcutaneous | SUPPL-1 | Eli Lilly and Co | Labeling | Approved |
Omvoh
BLA #761279 |
Mirikizumab-Mrkz | Injectable; Subcutaneous | SUPPL-1 | Eli Lilly and Co | Labeling | Approved |
Omvoh
BLA #761279 |
Mirikizumab-Mrkz | Injectable; Subcutaneous | SUPPL-1 | Eli Lilly and Co | Labeling | Approved |
Omvoh
BLA #761279 |
Mirikizumab-Mrkz | Vial; Single-Use | SUPPL-1 | Eli Lilly and Co | Labeling | Approved |
Omvoh
BLA #761279 |
Mirikizumab-Mrkz | Vial; Single-Use | SUPPL-1 | Eli Lilly and Co | Labeling | Approved |
Omvoh
BLA #761279 |
Mirikizumab-Mrkz | Vial; Single-Use | SUPPL-1 | Eli Lilly and Co | Labeling | Approved |
Tagrisso
NDA #208065 |
Osimertinib Mesylate | Tablet; Oral | SUPPL-31 | Astrazeneca | Labeling | Approved |
Tivdak
BLA #761208 |
Tisotumab Vedotin-Tftv | Injectable; Injection | SUPPL-7 | Seagen | Efficacy | Approved |
Tretinoin
ANDA #217804 |
Tretinoin | Cream; Topical | ORIG-1 | Alembic | Approved | |
Truvada
NDA #021752 |
Emtricitabine; Tenofovir Disoproxil Fumarate | Tablet; Oral | SUPPL-64 | Gilead | Labeling | Approved |
Truvada
NDA #021752 |
Emtricitabine; Tenofovir Disoproxil Fumarate | Tablet; Oral | SUPPL-64 | Gilead | Labeling | Approved |
April 26, 2024
Drug Name and Application Number | Active Ingredient | Dosage Form/ Route | Submission | Company | Submission Classification | Submission Status |
---|---|---|---|---|---|---|
Acetaminophen and Ibuprofen
ANDA #218311 |
Acetaminophen; Ibuprofen | Tablet; Oral | ORIG-1 | Glenmark Pharms Ltd | Approved | |
Amoxicillin and Clavulanate Potassium
ANDA #065162 |
Amoxicillin; Clavulanate Potassium | For Suspension; Oral | SUPPL-36 | Teva | Labeling | Approved |
Amoxicillin and Clavulanate Potassium
ANDA #065162 |
Amoxicillin; Clavulanate Potassium | For Suspension; Oral | SUPPL-29 | Teva | Labeling | Approved |
Amoxicillin and Clavulanate Potassium
ANDA #065162 |
Amoxicillin; Clavulanate Potassium | For Suspension; Oral | SUPPL-32 | Teva | Labeling | Approved |
Amoxicillin and Clavulanate Potassium
ANDA #065162 |
Amoxicillin; Clavulanate Potassium | For Suspension; Oral | SUPPL-36 | Teva | Labeling | Approved |
Clindamycin Phosphate
ANDA #064050 |
Clindamycin Phosphate | Solution; Topical | SUPPL-24 | Padagis Us | Manufacturing (CMC) | Approved |
Clindamycin Phosphate
ANDA #064050 |
Clindamycin Phosphate | Solution; Topical | SUPPL-24 | Padagis Us | Manufacturing (CMC) | Approved |
Libervant
NDA #218623 |
Diazepam | Film; Buccal | ORIG-1 | Aquestive Therapeutics Inc | Type 9 - New Indication Submitted as Distinct NDA, Consolidated with Original NDA after Approval | Approved |
Rinvoq
NDA #211675 |
Upadacitinib | Tablet, Extended Release; Oral | SUPPL-21 | Abbvie | Efficacy | Approved |
Rinvoq
NDA #211675 |
Upadacitinib | Tablet, Extended Release; Oral | SUPPL-22 | Abbvie | Efficacy | Approved |
Rinvoq
NDA #218347 |
Upadacitinib | Tablet, Extended Release; Oral | ORIG-1 | Abbvie Inc | Type 3 - New Dosage Form | Approved |
Rinvoq Lq
NDA #218347 |
Upadacitinib | Solution; Oral | ORIG-1 | Abbvie Inc | Type 3 - New Dosage Form | Approved |
Xolremdi
NDA #218709 |
Mavorixafor | Capsule; Oral | ORIG-1 | X4 Pharmaceuticals Inc | Type 1 - New Molecular Entity | Approved |
Zilbrysq
NDA #216834 |
Zilucoplan Sodium | Solution; Subcutaneous | SUPPL-1 | Ucb Inc | Labeling | Approved |
April 25, 2024
Drug Name and Application Number | Active Ingredient | Dosage Form/ Route | Submission | Company | Submission Classification | Submission Status |
---|---|---|---|---|---|---|
Amoxicillin
ANDA #062881 |
Amoxicillin | Capsule; Oral | SUPPL-26 | Strides Pharma | Labeling | Approved |
Amoxicillin
ANDA #062881 |
Amoxicillin | Capsule; Oral | SUPPL-27 | Strides Pharma | Labeling | Approved |
Amoxicillin
ANDA #062881 |
Amoxicillin | Capsule; Oral | SUPPL-28 | Strides Pharma | Labeling | Approved |
Amoxicillin
ANDA #062884 |
Amoxicillin | Capsule; Oral | SUPPL-24 | Strides Pharma | Labeling | Approved |
Amoxicillin
ANDA #062884 |
Amoxicillin | Capsule; Oral | SUPPL-23 | Strides Pharma | Labeling | Approved |
Amoxicillin
ANDA #062884 |
Amoxicillin | Capsule; Oral | SUPPL-24 | Strides Pharma | Labeling | Approved |
Amoxicillin
ANDA #062884 |
Amoxicillin | Capsule; Oral | SUPPL-25 | Strides Pharma | Labeling | Approved |
Amoxicillin
ANDA #064076 |
Amoxicillin | Capsule; Oral | SUPPL-37 | Sandoz | Labeling | Approved |
Amoxicillin
ANDA #064139 |
Amoxicillin | Tablet, Chewable; Oral | SUPPL-13 | Chartwell Rx | Labeling | Approved |
Amoxicillin
ANDA #064139 |
Amoxicillin | Tablet, Chewable; Oral | SUPPL-14 | Chartwell Rx | Labeling | Approved |
Amoxicillin
ANDA #064139 |
Amoxicillin | Tablet, Chewable; Oral | SUPPL-15 | Chartwell Rx | Labeling | Approved |
Amoxicillin
ANDA #065228 |
Amoxicillin | Tablet; Oral | SUPPL-17 | Sandoz | Labeling | Approved |
Amoxicillin
ANDA #065228 |
Amoxicillin | Tablet; Oral | SUPPL-17 | Sandoz | Labeling | Approved |
Amoxicillin
ANDA #065228 |
Amoxicillin | Tablet; Oral | SUPPL-19 | Sandoz | Labeling | Approved |
Amoxicillin
ANDA #065255 |
Amoxicillin | Tablet; Oral | SUPPL-25 | Hikma | Labeling | Approved |
Amoxicillin
ANDA #065325 |
Amoxicillin | For Suspension; Oral | SUPPL-32 | Hikma | Labeling | Approved |
Amoxicillin
ANDA #065344 |
Amoxicillin | Tablet; Oral | SUPPL-5 | Chartwell Rx | Labeling | Approved |
Amoxicillin
ANDA #065344 |
Amoxicillin | Tablet; Oral | SUPPL-6 | Chartwell Rx | Labeling | Approved |
Amoxicillin
ANDA #065344 |
Amoxicillin | Tablet; Oral | SUPPL-7 | Chartwell Rx | Labeling | Approved |
Amoxicillin
ANDA #065378 |
Amoxicillin | For Suspension; Oral | SUPPL-18 | Sandoz | Labeling | Approved |
Amoxicillin
ANDA #065387 |
Amoxicillin | For Suspension; Oral | SUPPL-18 | Sandoz | Labeling | Approved |
Amoxicillin and Clavulanate Potassium
ANDA #201090 |
Amoxicillin; Clavulanate Potassium | For Suspension; Oral | SUPPL-11 | Aurobindo Pharma Ltd | Labeling | Approved |
Amoxicillin and Clavulanate Potassium
ANDA #201090 |
Amoxicillin; Clavulanate Potassium | For Suspension; Oral | SUPPL-5 | Aurobindo Pharma Ltd | Labeling | Approved |
Amoxicillin and Clavulanate Potassium
ANDA #201090 |
Amoxicillin; Clavulanate Potassium | For Suspension; Oral | SUPPL-11 | Aurobindo Pharma Ltd | Labeling | Approved |
Amrix
NDA #021777 |
Cyclobenzaprine Hydrochloride | Capsule, Extended Release; Oral | SUPPL-19 | Teva Pharms Intl | Labeling | Approved |
Brinzolamide
ANDA #204884 |
Brinzolamide | Suspension/Drops; Ophthalmic | SUPPL-7 | Bausch and Lomb | Labeling | Approved |
Cetrorelix Acetate
ANDA #218150 |
Cetrorelix Acetate | Powder; Subcutaneous | ORIG-1 | Gland | Approved | |
Deflazacort
ANDA #217813 |
Deflazacort | Suspension; Oral | ORIG-1 | Tris Pharma Inc | Approved | |
Diazepam
ANDA #218450 |
Diazepam | Injectable; Injection | ORIG-1 | Alembic | Approved | |
Digoxin
NDA #021648 |
Digoxin | Elixir; Oral | SUPPL-15 | Hikma | Labeling | Approved |
Digoxin
NDA #021648 |
Digoxin | Elixir; Oral | SUPPL-15 | Hikma | Labeling | Approved |
Eslicarbazepine Acetate
ANDA #211247 |
Eslicarbazepine Acetate | Unknown | ORIG-1 | Sph Shanghai Zhongxi Pharma Co Ltd | Tentative Approval | |
Galzin
NDA #020458 |
Zinc Acetate | Capsule; Oral | SUPPL-9 | Teva | Labeling | Approved |
Hercessi
BLA #761346 |
Trastuzumab-Strf | Injectable; Injection | ORIG-1 | Accord Biopharma Inc. | Approved | |
Otezla
NDA #205437 |
Apremilast | Tablet; Oral | SUPPL-13 | Amgen Inc | Efficacy | Approved |
Safinamide Mesylate
ANDA #215739 |
Safinamide Mesylate | Tablet; Oral | ORIG-1 | Prinston Inc | Approved | |
Sevelamer Carbonate
ANDA #207291 |
Sevelamer Carbonate | For Suspension; Oral | ORIG-1 | Macleods Pharms Ltd | Approved | |
Trandate
NDA #018716 |
Labetalol Hydrochloride | Tablet; Oral | SUPPL-36 | Alvogen | Labeling | Approved |
Tretinoin
ANDA #218561 |
Tretinoin | Cream; Topical | ORIG-1 | Zydus Lifesciences | Approved | |
Viorele
ANDA #091346 |
Desogestrel; Ethinyl Estradiol | Tablet; Oral-28 | SUPPL-16 | Glenmark Pharms Ltd | Manufacturing (CMC) | Approved |
Zinc Chloride In Plastic Container
NDA #018959 |
Zinc Chloride | Injectable; Injection | SUPPL-32 | Hospira | Labeling | Approved |
April 24, 2024
Drug Name and Application Number | Active Ingredient | Dosage Form/ Route | Submission | Company | Submission Classification | Submission Status |
---|---|---|---|---|---|---|
Amoxicillin and Clavulanate Potassium
ANDA #065089 |
Amoxicillin; Clavulanate Potassium | For Suspension; Oral | SUPPL-26 | Teva | Labeling | Approved |
Amoxicillin and Clavulanate Potassium
ANDA #065089 |
Amoxicillin; Clavulanate Potassium | For Suspension; Oral | SUPPL-21 | Teva | Labeling | Approved |
Amoxicillin and Clavulanate Potassium
ANDA #065089 |
Amoxicillin; Clavulanate Potassium | For Suspension; Oral | SUPPL-26 | Teva | Labeling | Approved |
Amoxicillin and Clavulanate Potassium
ANDA #065096 |
Amoxicillin; Clavulanate Potassium | Tablet; Oral | SUPPL-36 | Teva Pharms Usa | Labeling | Approved |
Amoxicillin and Clavulanate Potassium
ANDA #065096 |
Amoxicillin; Clavulanate Potassium | Tablet; Oral | SUPPL-33 | Teva Pharms Usa | Labeling | Approved |
Amoxicillin and Clavulanate Potassium
ANDA #065096 |
Amoxicillin; Clavulanate Potassium | Tablet; Oral | SUPPL-36 | Teva Pharms Usa | Labeling | Approved |
Amoxicillin and Clavulanate Potassium
ANDA #065101 |
Amoxicillin; Clavulanate Potassium | Tablet; Oral | SUPPL-35 | Teva | Labeling | Approved |
Amoxicillin and Clavulanate Potassium
ANDA #065101 |
Amoxicillin; Clavulanate Potassium | Tablet; Oral | SUPPL-32 | Teva | Labeling | Approved |
Amoxicillin and Clavulanate Potassium
ANDA #065101 |
Amoxicillin; Clavulanate Potassium | Tablet; Oral | SUPPL-35 | Teva | Labeling | Approved |
Amoxicillin and Clavulanate Potassium
ANDA #065205 |
Amoxicillin; Clavulanate Potassium | Tablet, Chewable; Oral | SUPPL-26 | Teva | Labeling | Approved |
Amoxicillin and Clavulanate Potassium
ANDA #065205 |
Amoxicillin; Clavulanate Potassium | Tablet, Chewable; Oral | SUPPL-19 | Teva | Labeling | Approved |
Amoxicillin and Clavulanate Potassium
ANDA #065205 |
Amoxicillin; Clavulanate Potassium | Tablet, Chewable; Oral | SUPPL-26 | Teva | Labeling | Approved |
Ampicillin Sodium
ANDA #065499 |
Ampicillin Sodium | Injectable; Injection | SUPPL-11 | Eugia Pharma Speclts | Labeling | Approved |
Ampicillin Trihydrate
ANDA #061502 |
Ampicillin/Ampicillin Trihydrate | Capsule; Oral | SUPPL-138 | Chartwell Rx | Labeling | Approved |
Ampicillin Trihydrate
ANDA #061502 |
Ampicillin/Ampicillin Trihydrate | Capsule; Oral | SUPPL-139 | Chartwell Rx | Labeling | Approved |
Biktarvy
NDA #210251 |
Bictegravir Sodium; Emtricitabine; Tenofovir Alafenamide Fumarate | Tablet; Oral | SUPPL-19 | Gilead Sciences Inc | Efficacy | Approved |
Cetrorelix Acetate
ANDA #214540 |
Cetrorelix Acetate | Powder; Subcutaneous | ORIG-1 | Livzon Grp | Approved | |
Clinolipid 20%
NDA #204508 |
Olive Oil; Soybean Oil | Emulsion; Intravenous | SUPPL-22 | Baxter Hlthcare Corp | Efficacy | Approved |
Fenofibrate
ANDA #218548 |
Fenofibrate | Tablet; Oral | ORIG-1 | Yichang Humanwell | Approved | |
Lacosamide
ANDA #214695 |
Lacosamide | Tablet; Oral | SUPPL-2 | Alkem Labs Ltd | Labeling | Approved |
Lacosamide
ANDA #214695 |
Lacosamide | Tablet; Oral | SUPPL-4 | Alkem Labs Ltd | Labeling | Approved |
Lacosamide
ANDA #214695 |
Lacosamide | Tablet; Oral | SUPPL-7 | Alkem Labs Ltd | Labeling | Approved |
Lacosamide
ANDA #214695 |
Lacosamide | Tablet; Oral | SUPPL-2 | Alkem Labs Ltd | Labeling | Approved |
Lacosamide
ANDA #214695 |
Lacosamide | Tablet; Oral | SUPPL-4 | Alkem Labs Ltd | Labeling | Approved |
Lacosamide
ANDA #214695 |
Lacosamide | Tablet; Oral | SUPPL-6 | Alkem Labs Ltd | Labeling | Approved |
Lacosamide
ANDA #214695 |
Lacosamide | Tablet; Oral | SUPPL-7 | Alkem Labs Ltd | Labeling | Approved |
Loteprednol Etabonate
ANDA #215719 |
Loteprednol Etabonate | Suspension/Drops; Ophthalmic | ORIG-1 | Lupin Ltd | Approved | |
Norethindrone Acetate and Ethinyl Estradiol
ANDA #202770 |
Ethinyl Estradiol; Norethindrone Acetate | Tablet; Oral-21 | SUPPL-9 | Mylan Labs Ltd | Labeling | Approved |
Norethindrone Acetate and Ethinyl Estradiol
ANDA #202770 |
Ethinyl Estradiol; Norethindrone Acetate | Tablet; Oral-21 | SUPPL-7 | Mylan Labs Ltd | Labeling | Approved |
Norethindrone Acetate and Ethinyl Estradiol
ANDA #202770 |
Ethinyl Estradiol; Norethindrone Acetate | Tablet; Oral-21 | SUPPL-9 | Mylan Labs Ltd | Labeling | Approved |
Nortriptyline Hydrochloride
ANDA #074132 |
Nortriptyline Hydrochloride | Capsule; Oral | SUPPL-31 | Teva | Labeling | Approved |
Nortriptyline Hydrochloride
ANDA #074132 |
Nortriptyline Hydrochloride | Capsule; Oral | SUPPL-31 | Teva | Labeling | Approved |
Nortriptyline Hydrochloride
ANDA #074132 |
Nortriptyline Hydrochloride | Capsule; Oral | SUPPL-31 | Teva | Labeling | Approved |
Piperacillin and Tazobactam
ANDA #065363 |
Piperacillin Sodium; Tazobactam Sodium | Injectable; Injection | SUPPL-39 | Sandoz | Labeling | Approved |
Piperacillin and Tazobactam
ANDA #065363 |
Piperacillin Sodium; Tazobactam Sodium | Injectable; Injection | SUPPL-39 | Sandoz | Labeling | Approved |
Piperacillin and Tazobactam
ANDA #065363 |
Piperacillin Sodium; Tazobactam Sodium | Injectable; Injection | SUPPL-40 | Sandoz | Labeling | Approved |
Piperacillin and Tazobactam
ANDA #065363 |
Piperacillin Sodium; Tazobactam Sodium | Injectable; Injection | SUPPL-39 | Sandoz | Labeling | Approved |
Pivya
NDA #216483 |
Amdinocillin Pivoxil | Tablet; Oral | ORIG-1 | Utility Therapeutics Ltd | Type 2 - New Active Ingredient | Approved |
Vijoice
NDA #215039 |
Alpelisib | Tablet; Oral | SUPPL-2 | Novartis | Efficacy | Approved |
Vijoice
NDA #218466 |
Alpelisib | Granules; Oral | ORIG-1 | Novartis Pharms Corp | Type 3 - New Dosage Form | Approved |
Vijoice
NDA #218466 |
Alpelisib | Tablet; Oral | ORIG-1 | Novartis Pharms Corp | Type 3 - New Dosage Form | Approved |
April 23, 2024
Drug Name and Application Number | Active Ingredient | Dosage Form/ Route | Submission | Company | Submission Classification | Submission Status |
---|---|---|---|---|---|---|
Amoxicillin
ANDA #062927 |
Amoxicillin | For Suspension; Oral | SUPPL-26 | Dava Pharms Inc | Labeling | Approved |
Amoxicillin
ANDA #062927 |
Amoxicillin | For Suspension; Oral | SUPPL-27 | Dava Pharms Inc | Labeling | Approved |
Amoxicillin
ANDA #062927 |
Amoxicillin | For Suspension; Oral | SUPPL-28 | Dava Pharms Inc | Labeling | Approved |
Amoxicillin and Clavulanate Potassium
ANDA #065191 |
Amoxicillin; Clavulanate Potassium | For Suspension; Oral | SUPPL-32 | Hikma Pharms | Labeling | Approved |
Atorvaliq
NDA #213260 |
Atorvastatin Calcium | Suspension; Oral | SUPPL-2 | Cmp Dev Llc | Labeling | Approved |
Cambia
NDA #022165 |
Diclofenac Potassium | For Solution; Oral | SUPPL-6 | Assertio | Labeling | Approved |
Gleolan
NDA #208630 |
Aminolevulinic Acid Hydrochloride | For Solution; Oral | SUPPL-7 | Nxdc | Labeling | Approved |
Levetiracetam
ANDA #091261 |
Levetiracetam | Tablet, Extended Release; Oral | SUPPL-15 | Apotex Inc | Labeling | Approved |
Levetiracetam
ANDA #202958 |
Levetiracetam | Tablet, Extended Release; Oral | SUPPL-7 | Apotex | Labeling | Approved |
Lutathera
NDA #208700 |
Lutetium Lu 177 Dotatate | Solution; Intravenous | SUPPL-31 | Aaa Usa Inc | Efficacy | Approved |
Mometasone Furoate
ANDA #217438 |
Mometasone Furoate | Spray, Metered; Nasal | ORIG-1 | Apotex | Approved | |
Naloxone Hydrochloride
ANDA #217992 |
Naloxone Hydrochloride | Spray, Metered; Nasal | ORIG-1 | Amneal | Approved | |
Ojemda
NDA #217700 |
Tovorafenib | Suspension; Oral | ORIG-1 | Day One Biopharmaceuticals Inc | Type 1 - New Molecular Entity | Approved |
Ojemda
NDA #217700 |
Tovorafenib | Tablet; Oral | ORIG-1 | Day One Biopharmaceuticals Inc | Type 1 - New Molecular Entity | Approved |
Ojemda
NDA #218033 |
Tovorafenib | Suspension; Oral | ORIG-1 | Day One Biopharmaceuticals Inc | Type 1 - New Molecular Entity | Approved |
Ojemda
NDA #218033 |
Tovorafenib | Tablet; Oral | ORIG-1 | Day One Biopharmaceuticals Inc | Type 1 - New Molecular Entity | Approved |
Pantoprazole Sodium
ANDA #217416 |
Pantoprazole Sodium | For Suspension, Delayed Release; Oral | SUPPL-2 | Ajanta Pharma Ltd | Labeling | Approved |
Pazopanib Hydrochloride
ANDA #218231 |
Pazopanib Hydrochloride | Tablet; Oral | ORIG-1 | Novugen | Approved | |
Rabeprazole Sodium
ANDA #202376 |
Rabeprazole Sodium | Tablet, Delayed Release; Oral | SUPPL-20 | Torrent | Labeling | Approved |
Rabeprazole Sodium
ANDA #202376 |
Rabeprazole Sodium | Tablet, Delayed Release; Oral | SUPPL-20 | Torrent | Labeling | Approved |
Verapamil Hydrochloride
ANDA #216471 |
Verapamil Hydrochloride | Injectable; Injection | ORIG-1 | Fresenius Kabi Usa | Approved |
April 22, 2024
Drug Name and Application Number | Active Ingredient | Dosage Form/ Route | Submission | Company | Submission Classification | Submission Status |
---|---|---|---|---|---|---|
Anktiva
BLA #761336 |
Nogapendekin Alfa Inbakicept-Pmln | Solution; Intravesical | ORIG-1 | Altor Bioscience, Llc, An Indirect Wholly-Owned Su | Type 1 - New Molecular Entity | Approved |
Enzalutamide
ANDA #218187 |
Enzalutamide | Tablet; Oral | ORIG-1 | Teva Pharms Inc | Tentative Approval | |
Estradiol
ANDA #216160 |
Estradiol | Gel, Metered; Transdermal | ORIG-1 | Solaris Pharma Corp | Approved | |
Extraneal
NDA #021321 |
Icodextrin | Solution; Intraperitoneal | SUPPL-38 | Baxter Hlthcare | Labeling | Approved |
Imfinzi
BLA #761069 |
Durvalumab | Injectable; Injection | SUPPL-48 | Astrazeneca Uk Ltd | Labeling | Approved |
Loqtorzi
BLA #761240 |
Toripalimab-Tpzi | Injectable; Injection | SUPPL-1 | Coherus Biosciences Inc | Labeling | Approved |
Minoxidil (For Men)
ANDA #218616 |
Minoxidil | Aerosol, Foam; Topical | ORIG-1 | Aurobindo Pharma | Approved | |
Minoxidil (For Women)
ANDA #218616 |
Minoxidil | Aerosol, Foam; Topical | ORIG-1 | Aurobindo Pharma | Approved | |
Tecentriq
BLA #761034 |
Atezolizumab | Injectable; Injection | SUPPL-53 | Genentech Inc | Labeling | Approved |
Zynyz
BLA #761334 |
Retifanlimab-Dlwr | Injectable; Intravenous | SUPPL-2 | Incyte Corp | Labeling | Approved |